≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Family history of other specific disorders

DOID Endpoint Browser

Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z83
  • Cause of death: ICD-10 — Z83

2 out of 7 registries used, show all original rules.

559

4. Check minimum number of events

None

559

5. Include endpoints

None

559

6. Filter based on genotype QC (FinnGen only)

536

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[8-9]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 536 409 127
Unadjusted period prevalence (%) 0.12 0.15 0.06
Median age at first event (years) 41.76 40.17 46.87

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
559
Matched controls
5590
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z31.5
ICD-10 Finland
Genetic counselling
34.1
307.7
244
124
Z83.4
ICD-10 Finland
Family history of other endocrine, nutritional and metabolic diseases
3932.3
282.1
248
*
Z83.2
ICD-10 Finland
Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
+∞
131.6
121
*
Z83.5
ICD-10 Finland
Family history of eye and ear disorders
+∞
123.6
114
*
Z83.7
ICD-10 Finland
Family history of diseases of the digestive system
+∞
26.3
25
*
Z83.3
ICD-10 Finland
Family history of diabetes mellitus
+∞
24.1
23
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.1
19.1
34
59
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
7.1
17.1
26
38
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
+∞
15.7
15
*
WX720
NOMESCO Finland
Own respiration
4.2
15.4
43
110
Z83.6
ICD-10 Finland
Family history of diseases of the respiratory system
+∞
14.6
14
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
153.9
14.5
15
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.5
12.6
44
132
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
12.5
12
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
132.9
12.5
13
*
SPAT1263
SPAT
Sampling
1.9
11.2
247
1675
H40.0
ICD-10 Finland
Glaucoma suspect
3.1
10.5
46
159
Z84.8
ICD-10 Finland
Family history of other specified conditions
112.0
10.5
11
*
Z83.1
ICD-10 Finland
Family history of other infectious and parasitic diseases
+∞
10.4
10
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
10.1
52
197
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.7
9.9
32
91
WX872
NOMESCO Finland
Intensive care
4.8
9.8
22
47
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
20.5
9.8
14
7
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
8.9
9.4
19
22
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.7
9.1
49
190
WX704
NOMESCO Finland
Intubation
2.5
8.7
55
231
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
9.6
7.8
15
16
OAB50, ,
SPAT
2.7
7.5
42
166
SPAT1262
SPAT
Handing over of treatment supplies
2.1
7.4
72
364
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
81.1
7.4
8
*
BBA50
NOMESCO Finland
Total parathyroidectomy
+∞
7.3
7
*
F38
ICPC
Eye, Other laboratory test NEC
5.7
7.1
19
34
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
6.9
120
740
SPAT1301
SPAT
No procedures
1.7
6.6
165
1123
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
12.4
6.6
11
9
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
6.6
105
630
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.0
6.3
74
401
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
+∞
6.3
6
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
6.3
6
*
D66
ICD-10 Finland
Hereditary factor VIII deficiency
+∞
6.3
6
*
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
+∞
6.3
6
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
+∞
6.3
6
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
1.9
6.2
81
455
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
10.2
6.1
11
11
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
6.0
193
1393

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Genetic counselling
Z31.5 [45590715]
1.4e+00
4.2e+00
—
1.0e+50
1.0e+50
5.2e+00
2.4e+00
cases:2.38%
controls:0.57%
cases:6.03%
controls:0.09%
—
—
cases:30.53%
controls:0.00%
cases:2.93%
controls:0.00%
cases:14.69%
controls:0.10%
cases:4.84%
controls:0.45%
13
31
534
5420
33
5
514
5446
—
167
0
380
5451
16
0
531
5439
78
5
453
5252
22
20
433
4457
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
1.5e+00
—
1.0e+50
1.0e+50
1.0e+50
5.5e+00
2.5e+00
cases:3.29%
controls:0.79%
—
—
cases:2.01%
controls:0.00%
cases:57.04%
controls:0.00%
cases:4.02%
controls:0.00%
cases:24.67%
controls:0.13%
cases:4.62%
controls:0.40%
18
43
529
5408
—
11
0
536
5451
312
0
235
5451
22
0
525
5439
131
7
400
5250
21
18
434
4459
Outpatient Visit
OP [9202]
1.8e-01
4.8e-01
5.1e-01
5.6e+00
6.7e-01
9.3e-01
6.6e-01
cases:76.05%
controls:72.54%
cases:62.16%
controls:50.41%
cases:15.17%
controls:9.70%
cases:53.56%
controls:0.44%
cases:19.20%
controls:10.88%
cases:70.06%
controls:47.99%
cases:85.49%
controls:75.36%
416
3954
131
1497
340
2748
207
2703
83
529
464
4922
293
24
254
5427
105
592
442
4847
372
2523
159
2734
389
3374
66
1103
Check up of cardiac pacemaker
XFP20 [2001303367]
2.2e+00
2.3e+00
—
—
—
2.1e+00
2.1e+00
cases:1.10%
controls:0.13%
cases:1.10%
controls:0.11%
—
—
—
—
—
—
cases:0.94%
controls:0.11%
cases:1.76%
controls:0.22%
6
7
541
5444
6
6
541
5445
—
—
—
5
6
526
5251
8
10
447
4467
Glaucoma suspect
H40.0 [45567051]
9.2e-01
2.4e+00
—
1.0e+50
—
2.6e+00
1.5e+00
cases:1.46%
controls:0.59%
cases:2.93%
controls:0.28%
—
—
cases:3.11%
controls:0.00%
—
—
cases:2.82%
controls:0.21%
cases:3.30%
controls:0.78%
8
32
539
5419
16
15
531
5436
—
17
0
530
5451
—
15
11
516
5246
15
35
440
4442
Specialised imaging for glaucoma
CS5Z4 [2001301479]
—
2.4e+00
—
—
—
—
2.8e+00
—
—
cases:1.46%
controls:0.13%
—
—
—
—
—
—
—
—
cases:3.74%
controls:0.25%
—
8
7
539
5444
—
—
—
—
17
11
438
4466
Gastroenterology
10 [38004455]
6.4e-01
7.7e-01
1.1e+00
1.0e+50
1.6e+00
1.1e+00
8.2e-01
cases:8.41%
controls:4.62%
cases:4.39%
controls:2.07%
cases:0.91%
controls:0.29%
cases:1.28%
controls:0.00%
cases:1.46%
controls:0.29%
cases:5.65%
controls:1.88%
cases:9.67%
controls:4.51%
46
252
501
5199
24
113
523
5338
5
16
542
5435
7
0
540
5451
8
16
539
5423
30
99
501
5158
44
202
411
4275
Supplier / Service Provider
OMOP5117446 [33004]
-6.5e-01
-4.0e-01
8.1e-02
—
—
2.6e+00
2.9e+00
cases:17.92%
controls:29.43%
cases:6.03%
controls:8.71%
cases:0.91%
controls:0.84%
—
—
—
—
cases:4.90%
controls:0.38%
cases:15.16%
controls:0.94%
98
1604
449
3847
33
475
514
4976
5
46
542
5405
—
—
26
20
505
5237
69
42
386
4435
Office Visit
OMOP4822458 [581477]
2.3e-01
6.2e-01
1.0e+00
1.0e+50
2.3e+00
1.5e+00
7.0e-01
cases:9.32%
controls:7.56%
cases:4.02%
controls:2.20%
cases:0.91%
controls:0.33%
cases:4.20%
controls:0.00%
cases:1.65%
controls:0.17%
cases:6.78%
controls:1.67%
cases:9.89%
controls:5.18%
51
412
496
5039
22
120
525
5331
5
18
542
5433
23
0
524
5451
9
9
538
5430
36
88
495
5169
45
232
410
4245
Pregnancy
W78 [2002001269]
3.1e-01
7.9e-01
1.3e+00
—
1.3e+00
9.2e-01
4.9e-01
cases:6.58%
controls:4.93%
cases:5.85%
controls:2.73%
cases:3.11%
controls:0.83%
—
—
cases:2.93%
controls:0.79%
cases:5.46%
controls:2.24%
cases:8.13%
controls:5.16%
36
269
511
5182
32
149
515
5302
17
45
530
5406
—
16
43
531
5396
29
118
502
5139
37
231
418
4246
Case Management Agency
251B00000X [38004193]
9.4e-02
1.7e-01
4.2e-01
3.9e+00
3.0e-01
1.1e-01
1.4e-01
cases:67.64%
controls:65.55%
cases:63.44%
controls:59.44%
cases:33.82%
controls:25.11%
cases:41.32%
controls:1.39%
cases:32.91%
controls:26.68%
cases:63.65%
controls:60.99%
cases:76.70%
controls:74.13%
370
3573
177
1878
347
3240
200
2211
185
1369
362
4082
226
76
321
5375
180
1451
367
3988
338
3206
193
2051
349
3319
106
1158
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
2.1e+00
—
—
—
—
2.2e+00
—
cases:1.65%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.15%
—
—
9
11
538
5440
—
—
—
—
7
8
524
5249
—
Other single spontaneous delivery
O80.8 [45534307]
8.1e-01
2.1e+00
—
—
—
2.1e+00
7.8e-01
cases:1.83%
controls:0.83%
cases:1.65%
controls:0.20%
—
—
—
—
—
—
cases:1.69%
controls:0.21%
cases:1.98%
controls:0.92%
10
45
537
5406
9
11
538
5440
—
—
—
9
11
522
5246
9
41
446
4436
Laboratory Visit
OMOP4822461 [32036]
9.7e-02
1.4e-01
6.2e-01
2.7e+00
8.4e-01
2.4e-01
9.5e-02
cases:50.82%
controls:48.39%
cases:46.80%
controls:43.35%
cases:20.84%
controls:12.46%
cases:7.31%
controls:0.55%
cases:24.50%
controls:12.30%
cases:50.47%
controls:44.42%
cases:61.54%
controls:59.26%
278
2638
269
2813
256
2363
291
3088
114
679
433
4772
40
30
507
5421
134
669
413
4770
268
2335
263
2922
280
2653
175
1824
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14756-1 [3015024]
1.7e+00
—
—
—
—
2.3e+00
1.1e+00
cases:1.46%
controls:0.28%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.13%
cases:1.32%
controls:0.45%
8
15
539
5436
—
—
—
—
7
7
524
5250
6
20
449
4457
Obstetrics / Gynecology
16 [38004461]
2.4e-01
6.1e-01
1.0e+00
—
8.7e-01
7.3e-01
4.2e-01
cases:27.06%
controls:22.62%
cases:16.45%
controls:9.69%
cases:4.57%
controls:1.71%
—
—
cases:4.75%
controls:2.04%
cases:17.70%
controls:9.36%
cases:29.67%
controls:21.71%
148
1233
399
4218
90
528
457
4923
25
93
522
5358
—
26
111
521
5328
94
492
437
4765
135
972
320
3505
Health check-up of pregnant person
SPAT1379 [2001700479]
3.9e-01
9.0e-01
1.6e+00
—
1.2e+00
1.1e+00
6.6e-01
cases:5.85%
controls:4.05%
cases:4.39%
controls:1.83%
cases:2.93%
controls:0.61%
—
—
cases:1.83%
controls:0.53%
cases:4.14%
controls:1.37%
cases:5.71%
controls:3.04%
32
221
515
5230
24
100
523
5351
16
33
531
5418
—
10
29
537
5410
22
72
509
5185
26
136
429
4341
Maternal and Fetal Medicine
OMOP4821963 [45756780]
7.2e-01
1.4e+00
—
—
2.0e+00
1.5e+00
8.5e-01
cases:3.29%
controls:1.63%
cases:3.11%
controls:0.79%
—
—
—
—
cases:0.91%
controls:0.13%
cases:3.39%
controls:0.74%
cases:4.18%
controls:1.83%
18
89
529
5362
17
43
530
5408
—
—
5
7
542
5432
18
39
513
5218
19
82
436
4395
General anesthesia, balanced
WX408 [2001310808]
2.7e-01
9.9e-01
-1.0e+50
—
—
1.7e+00
1.1e+00
cases:4.02%
controls:3.10%
cases:1.28%
controls:0.48%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.07%
controls:0.38%
cases:3.74%
controls:1.30%
22
169
525
5282
7
26
540
5425
0
7
547
5444
—
—
11
20
520
5237
17
58
438
4419
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
1.5e-01
1.4e-01
8.5e-01
—
9.0e-01
4.6e-01
4.3e-01
cases:21.57%
controls:19.21%
cases:12.25%
controls:10.84%
cases:4.20%
controls:1.83%
—
—
cases:3.84%
controls:1.60%
cases:15.44%
controls:10.37%
cases:30.11%
controls:21.84%
118
1047
429
4404
67
591
480
4860
23
100
524
5351
—
21
87
526
5352
82
545
449
4712
137
978
318
3499
Presence of intraocular lens
Z96.1 [45585885]
-1.0e+50
-1.0e+50
—
1.0e+50
—
—
2.5e+00
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.13%
—
—
cases:1.65%
controls:0.00%
—
—
—
—
cases:3.74%
controls:0.31%
0
6
547
5445
0
7
547
5444
—
9
0
538
5451
—
—
17
14
438
4463
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
-1.0e+50
—
—
—
—
—
2.5e+00
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.11%
0
10
547
5441
—
—
—
—
—
6
5
449
4472
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.25%
—
—
—
—
—
—
13
11
442
4466
Pregnancy symptom/complaint other
W29 [2002001222]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.11%
—
—
—
—
—
—
—
7
6
524
5251
—
Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
14759-5 [3016701]
1.2e+00
—
—
—
—
2.5e+00
1.3e+00
cases:1.28%
controls:0.39%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.11%
cases:1.54%
controls:0.42%
7
21
540
5430
—
—
—
—
7
6
524
5251
7
19
448
4458
Destruction of lesion of head or neck
QAA25 [2001309763]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.13%
—
—
—
—
—
—
7
6
448
4471
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
4.1e-01
2.6e-01
—
—
—
1.4e+00
9.8e-01
cases:4.20%
controls:2.84%
cases:1.10%
controls:0.84%
—
—
—
—
—
—
cases:2.07%
controls:0.49%
cases:4.40%
controls:1.70%
23
155
524
5296
6
46
541
5405
—
—
—
11
26
520
5231
20
76
435
4401
Anion gap in Blood by calculation
41276-7 [3039000]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.20%
—
—
—
—
—
—
10
9
445
4468
Chloride [Moles/volume] in Blood
2069-3 [3018572]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.20%
controls:0.20%
—
—
—
—
—
—
10
9
445
4468
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
8.0e-01
8.9e-01
—
—
-1.0e+50
6.3e-01
7.1e-01
cases:6.76%
controls:3.16%
cases:4.02%
controls:1.69%
—
—
—
—
cases:0.00%
controls:0.11%
cases:2.82%
controls:1.52%
cases:6.81%
controls:3.48%
37
172
510
5279
22
92
525
5359
—
—
0
6
547
5433
15
80
516
5177
31
156
424
4321
Endocrinology
46 [38004485]
3.1e-01
3.1e-01
4.6e-01
1.0e+50
—
1.3e+00
9.8e-01
cases:5.30%
controls:3.94%
cases:3.29%
controls:2.44%
cases:1.10%
controls:0.70%
cases:4.20%
controls:0.00%
—
—
cases:8.47%
controls:2.42%
cases:12.09%
controls:4.89%
29
215
518
5236
18
133
529
5318
6
38
541
5413
23
0
524
5451
—
45
127
486
5130
55
219
400
4258
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
5.3e-01
1.0e+00
—
1.0e+50
—
7.9e-01
7.3e-01
cases:9.69%
controls:5.93%
cases:4.20%
controls:1.56%
—
—
cases:1.10%
controls:0.00%
—
—
cases:3.95%
controls:1.83%
cases:10.55%
controls:5.36%
53
323
494
5128
23
85
524
5366
—
6
0
541
5451
—
21
96
510
5161
48
240
407
4237
No procedures
SPAT1301 [2001700402]
6.7e-01
3.1e-01
—
-1.0e+50
—
8.9e-01
6.4e-01
cases:10.24%
controls:5.54%
cases:2.74%
controls:2.02%
—
—
cases:0.00%
controls:0.13%
—
—
cases:3.58%
controls:1.50%
cases:8.13%
controls:4.47%
56
302
491
5149
15
110
532
5341
—
0
7
547
5444
—
19
79
512
5178
37
200
418
4277
Primary hyperparathyroidism
E21.0 [45571667]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.18%
—
—
—
—
—
—
7
8
448
4469
Eye, Other laboratory test NEC
F38 [2002000421]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.18%
—
—
—
—
—
—
7
8
448
4469
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
3.7e-01
5.9e-01
—
—
—
1.2e+00
9.2e-01
cases:3.29%
controls:2.29%
cases:1.28%
controls:0.72%
—
—
—
—
—
—
cases:2.64%
controls:0.78%
cases:5.27%
controls:2.17%
18
125
529
5326
7
39
540
5412
—
—
—
14
41
517
5216
24
97
431
4380
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
2.0e-01
3.8e-01
2.2e+00
—
—
4.7e-01
3.9e-01
cases:2.01%
controls:1.65%
cases:1.10%
controls:0.75%
cases:1.10%
controls:0.13%
—
—
—
—
cases:0.94%
controls:0.59%
cases:2.64%
controls:1.81%
11
90
536
5361
6
41
541
5410
6
7
541
5444
—
—
5
31
526
5226
12
81
443
4396
Ulcerative colitis, unspecified
K51.9 [45605941]
9.7e-01
2.2e+00
—
—
—
1.4e+00
—
cases:0.91%
controls:0.35%
cases:1.10%
controls:0.13%
—
—
—
—
—
—
cases:0.94%
controls:0.23%
—
—
5
19
542
5432
6
7
541
5444
—
—
—
5
12
526
5245
—
Impacted cerumen
H61.2 [45562307]
—
—
—
—
—
2.1e+00
9.1e-01
—
—
—
—
—
—
—
—
—
—
cases:1.13%
controls:0.13%
cases:1.98%
controls:0.80%
—
—
—
—
—
6
7
525
5250
9
36
446
4441
Supervision of other high-risk pregnancies
Z35.8 [45552076]
4.0e-01
1.0e+00
—
1.0e+50
—
2.1e+00
4.9e-01
cases:2.01%
controls:1.36%
cases:1.28%
controls:0.46%
—
—
cases:1.46%
controls:0.00%
—
—
cases:2.82%
controls:0.34%
cases:2.64%
controls:1.63%
11
74
536
5377
7
25
540
5426
—
8
0
539
5451
—
15
18
516
5239
12
73
443
4404
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
8.5e-02
6.8e-01
—
—
8.0e-01
8.3e-01
6.1e-01
cases:11.33%
controls:10.51%
cases:7.68%
controls:4.04%
—
—
—
—
cases:1.10%
controls:0.50%
cases:7.53%
controls:3.42%
cases:17.36%
controls:10.27%
62
573
485
4878
42
220
505
5231
—
—
6
27
541
5412
40
180
491
5077
79
460
376
4017
Glucose [Moles/volume] in Serum or Plasma --baseline
14768-6 [3007821]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.18%
—
—
—
—
—
—
6
8
449
4469
Sick sinus syndrome
I49.5 [45562354]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.76%
controls:0.25%
—
—
—
—
—
—
8
11
447
4466
Lactate [Moles/volume] in Blood
32693-4 [3047181]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.64%
controls:0.38%
—
—
—
—
—
—
12
17
443
4460
Own respiration
WX720 [2001310823]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.08%
controls:0.49%
—
—
—
—
—
—
14
22
441
4455
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
3.6e-01
1.9e+00
—
—
—
1.4e+00
5.5e-01
cases:1.46%
controls:1.03%
cases:1.28%
controls:0.20%
—
—
—
—
—
—
cases:1.13%
controls:0.29%
cases:2.42%
controls:1.41%
8
56
539
5395
7
11
540
5440
—
—
—
6
15
525
5242
11
63
444
4414
Myopia
H52.1 [45533352]
9.2e-01
—
—
1.0e+50
—
1.9e+00
8.6e-01
cases:1.10%
controls:0.44%
—
—
—
—
cases:2.74%
controls:0.00%
—
—
cases:1.32%
controls:0.21%
cases:1.10%
controls:0.47%
6
24
541
5427
—
—
15
0
532
5451
—
7
11
524
5246
5
21
450
4456
Pediatric Medicine
37 [38004477]
-6.3e-02
1.6e-01
—
—
1.8e+00
4.5e-01
3.3e-01
cases:3.11%
controls:3.30%
cases:1.83%
controls:1.56%
—
—
—
—
cases:1.83%
controls:0.29%
cases:2.07%
controls:1.33%
cases:2.86%
controls:2.08%
17
180
530
5271
10
85
537
5366
—
—
10
16
537
5423
11
70
520
5187
13
93
442
4384
Hematology
82 [38004501]
5.1e-01
9.9e-01
—
—
2.0e+00
1.7e+00
8.8e-01
cases:1.65%
controls:0.99%
cases:1.46%
controls:0.55%
—
—
—
—
cases:0.91%
controls:0.13%
cases:2.45%
controls:0.44%
cases:1.98%
controls:0.83%
9
54
538
5397
8
30
539
5421
—
—
5
7
542
5432
13
23
518
5234
9
37
446
4440
Other and unspecified ovarian cysts
N83.2 [45539066]
4.9e-01
1.7e+00
—
—
—
1.4e+00
5.4e-01
cases:2.01%
controls:1.25%
cases:1.83%
controls:0.33%
—
—
—
—
—
—
cases:1.51%
controls:0.38%
cases:1.98%
controls:1.16%
11
68
536
5383
10
18
537
5433
—
—
—
8
20
523
5237
9
52
446
4425
Cardiology
6 [38004451]
2.4e-01
2.6e-01
—
—
1.3e+00
9.6e-01
7.5e-01
cases:6.76%
controls:5.41%
cases:3.29%
controls:2.55%
—
—
—
—
cases:1.28%
controls:0.35%
cases:5.27%
controls:2.09%
cases:12.09%
controls:6.08%
37
295
510
5156
18
139
529
5312
—
—
7
19
540
5420
28
110
503
5147
55
272
400
4205
Ophthalmology
18 [38004463]
-2.2e-02
7.4e-01
4.1e-01
1.0e+50
—
9.5e-01
3.9e-01
cases:11.33%
controls:11.56%
cases:10.24%
controls:5.16%
cases:1.10%
controls:0.73%
cases:15.54%
controls:0.00%
—
—
cases:11.11%
controls:4.62%
cases:17.58%
controls:12.60%
62
630
485
4821
56
281
491
5170
6
40
541
5411
85
0
462
5451
—
59
243
472
5014
80
564
375
3913
Uncompl labour/delivery livebirth
W90 [2002001277]
2.8e-01
1.0e+00
—
—
—
1.7e+00
6.9e-01
cases:1.28%
controls:0.97%
cases:0.91%
controls:0.33%
—
—
—
—
—
—
cases:1.51%
controls:0.29%
cases:2.42%
controls:1.23%
7
53
540
5398
5
18
542
5433
—
—
—
8
15
523
5242
11
55
444
4422
Zoster without complication
B02.9 [45581143]
—
-1.0e+50
—
—
—
-1.0e+50
1.6e+00
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.98%
controls:0.40%
—
0
8
547
5443
—
—
—
0
7
531
5250
9
18
446
4459
Assistance to normal delivery
MAX99 [2001306918]
5.3e-01
8.1e-01
—
—
—
1.6e+00
4.5e-01
cases:4.20%
controls:2.51%
cases:1.83%
controls:0.83%
—
—
—
—
—
—
cases:2.82%
controls:0.59%
cases:4.18%
controls:2.70%
23
137
524
5314
10
45
537
5406
—
—
—
15
31
516
5226
19
121
436
4356
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
MA2AE [2001306829]
3.2e-01
9.5e-01
1.8e+00
—
1.5e+00
7.4e-01
6.4e-01
cases:4.94%
controls:3.63%
cases:3.47%
controls:1.38%
cases:0.91%
controls:0.15%
—
—
cases:0.91%
controls:0.20%
cases:3.01%
controls:1.46%
cases:8.13%
controls:4.47%
27
198
520
5253
19
75
528
5376
5
8
542
5443
—
5
11
542
5428
16
77
515
5180
37
200
418
4277
False labour before 37 completed weeks of gestation
O47.0 [45582556]
-1.7e-01
—
—
—
—
1.5e+00
6.2e-01
cases:1.46%
controls:1.72%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.49%
cases:2.86%
controls:1.56%
8
94
539
5357
—
—
—
—
12
26
519
5231
13
70
442
4407
Noninvasive ventilation
WX725 [2001310828]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.64%
controls:0.58%
—
—
—
—
—
—
12
26
443
4451
latanoprost
S01EE01 [21603710]
4.8e-01
6.5e-01
—
—
—
1.5e+00
1.3e+00
cases:0.91%
controls:0.57%
cases:0.91%
controls:0.48%
—
—
—
—
—
—
cases:1.88%
controls:0.42%
cases:2.20%
controls:0.58%
5
31
542
5420
5
26
542
5425
—
—
—
10
22
521
5235
10
26
445
4451
Upper gastrointestinal surgery
106 [44777669]
1.8e-01
7.7e-01
—
—
—
5.6e-01
7.3e-01
cases:8.78%
controls:7.43%
cases:5.85%
controls:2.81%
—
—
—
—
—
—
cases:4.52%
controls:2.64%
cases:12.97%
controls:6.70%
48
405
499
5046
32
153
515
5298
—
—
—
24
139
507
5118
59
300
396
4177
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.64%
controls:0.60%
—
—
—
—
—
—
12
27
443
4450
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
—
—
—
—
—
-1.0e+50
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
cases:2.42%
controls:0.56%
—
—
—
—
—
0
11
531
5246
11
25
444
4452
Cathetrisation of artery
TPH07 [2001309747]
4.7e-01
—
—
—
—
—
1.5e+00
cases:1.28%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:3.08%
controls:0.71%
7
44
540
5407
—
—
—
—
—
14
32
441
4445
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.86%
controls:0.67%
—
—
—
—
—
—
13
30
442
4447
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
3.5e-01
1.4e+00
—
—
—
7.2e-01
9.1e-02
cases:2.38%
controls:1.69%
cases:2.19%
controls:0.53%
—
—
—
—
—
—
cases:1.32%
controls:0.65%
cases:1.76%
controls:1.61%
13
92
534
5359
12
29
535
5422
—
—
—
7
34
524
5223
8
72
447
4405
Postpartum check-up
SPAT1380 [2001700480]
2.3e-01
7.2e-01
—
—
—
1.4e+00
6.5e-01
cases:3.66%
controls:2.94%
cases:1.83%
controls:0.90%
—
—
—
—
—
—
cases:2.82%
controls:0.70%
cases:3.96%
controls:2.10%
20
160
527
5291
10
49
537
5402
—
—
—
15
37
516
5220
18
94
437
4383
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
3.2e-01
—
-1.0e+50
—
—
—
1.4e+00
cases:2.01%
controls:1.47%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:3.74%
controls:0.94%
11
80
536
5371
—
0
6
547
5445
—
—
—
17
42
438
4435
pH of Specimen
17433-4 [3019225]
1.6e-01
1.4e+00
—
—
-1.0e+50
4.1e-01
5.9e-01
cases:2.19%
controls:1.87%
cases:2.38%
controls:0.62%
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.32%
controls:0.88%
cases:2.86%
controls:1.61%
12
102
535
5349
13
34
534
5417
—
—
0
7
547
5432
7
46
524
5211
13
72
442
4405
Spontaneous vertex delivery
O80.0 [45577661]
2.9e-01
5.4e-02
—
—
—
1.3e+00
7.2e-02
cases:7.50%
controls:5.72%
cases:2.01%
controls:1.91%
—
—
—
—
—
—
cases:5.65%
controls:1.60%
cases:6.59%
controls:6.16%
41
312
506
5139
11
104
536
5347
—
—
—
30
84
501
5173
30
276
425
4201
Detailed ultrasound examination of fetus including color doppler method
MA2DE [2001306835]
5.3e-01
6.4e-01
—
—
2.1e+00
1.2e+00
7.9e-01
cases:3.11%
controls:1.85%
cases:1.28%
controls:0.68%
—
—
—
—
cases:0.91%
controls:0.11%
cases:2.82%
controls:0.84%
cases:4.62%
controls:2.14%
17
101
530
5350
7
37
540
5414
—
—
5
6
542
5433
15
44
516
5213
21
96
434
4381
dexamethasone
S01BA01 [21603618]
3.2e-01
1.2e+00
—
—
—
7.2e-01
2.4e-01
cases:2.93%
controls:2.15%
cases:2.56%
controls:0.77%
—
—
—
—
—
—
cases:1.51%
controls:0.74%
cases:3.74%
controls:2.97%
16
117
531
5334
14
42
533
5409
—
—
—
8
39
523
5218
17
133
438
4344
dexamethasone
S03BA01 [21605201]
3.2e-01
1.2e+00
—
—
—
7.2e-01
2.4e-01
cases:2.93%
controls:2.15%
cases:2.56%
controls:0.77%
—
—
—
—
—
—
cases:1.51%
controls:0.74%
cases:3.74%
controls:2.97%
16
117
531
5334
14
42
533
5409
—
—
—
8
39
523
5218
17
133
438
4344
Cough
R05 [2002000886]
4.3e-01
1.9e-01
—
—
—
1.2e+00
1.3e-01
cases:5.67%
controls:3.76%
cases:1.28%
controls:1.06%
—
—
—
—
—
—
cases:3.01%
controls:0.93%
cases:4.62%
controls:4.07%
31
205
516
5246
7
58
540
5393
—
—
—
16
49
515
5208
21
182
434
4295
Intubation
WX704 [2001310820]
6.1e-01
—
—
—
—
—
1.2e+00
cases:1.65%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:3.08%
controls:0.96%
9
49
538
5402
—
—
—
—
—
14
43
441
4434
Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
584-3 [3020321]
4.8e-01
1.6e+00
—
—
—
9.1e-01
1.2e+00
cases:2.38%
controls:1.49%
cases:1.28%
controls:0.26%
—
—
—
—
—
—
cases:1.32%
controls:0.53%
cases:4.18%
controls:1.32%
13
81
534
5370
7
14
540
5437
—
—
—
7
28
524
5229
19
59
436
4418
Outcome of delivery
Z37 [45581024]
3.4e-01
3.6e-01
—
—
1.2e+00
1.2e+00
2.5e-01
cases:12.61%
controls:9.30%
cases:4.39%
controls:3.10%
—
—
—
—
cases:0.91%
controls:0.28%
cases:8.85%
controls:2.89%
cases:11.87%
controls:9.49%
69
507
478
4944
24
169
523
5282
—
—
5
15
542
5424
47
152
484
5105
54
425
401
4052
Person consulting for explanation of investigation findings
Z71.2 [45552100]
-2.0e-02
2.8e-01
—
1.0e+50
1.5e+00
1.2e+00
-9.9e-02
cases:4.75%
controls:4.84%
cases:2.56%
controls:1.94%
—
—
cases:1.65%
controls:0.00%
cases:1.10%
controls:0.26%
cases:5.84%
controls:1.88%
cases:5.49%
controls:6.03%
26
264
521
5187
14
106
533
5345
—
9
0
538
5451
6
14
541
5425
31
99
500
5158
25
270
430
4207
Pain localized to other parts of lower abdomen
R10.3 [45534426]
3.8e-01
1.2e+00
-1.0e+50
—
-1.0e+50
3.4e-01
1.4e-01
cases:6.58%
controls:4.60%
cases:3.84%
controls:1.23%
cases:0.00%
controls:0.17%
—
—
cases:0.00%
controls:0.18%
cases:2.07%
controls:1.48%
cases:5.05%
controls:4.44%
36
251
511
5200
21
67
526
5384
0
9
547
5442
—
0
10
547
5429
11
78
520
5179
23
199
432
4278
Internal Medicine
11 [38004456]
1.1e-01
3.2e-02
4.4e-01
1.0e+50
1.1e+00
4.5e-01
2.1e-01
cases:16.82%
controls:15.39%
cases:6.03%
controls:5.85%
cases:1.28%
controls:0.83%
cases:3.84%
controls:0.00%
cases:2.56%
controls:0.83%
cases:8.66%
controls:5.73%
cases:15.82%
controls:13.22%
92
839
455
4612
33
319
514
5132
7
45
540
5406
21
0
526
5451
14
45
533
5394
46
301
485
4956
72
592
383
3885
Inpatient Hospital
21 [8717]
8.4e-02
2.6e-01
-6.0e-02
—
6.4e-01
7.5e-01
3.9e-01
cases:30.35%
controls:28.60%
cases:10.79%
controls:8.49%
cases:1.28%
controls:1.36%
—
—
cases:1.83%
controls:0.97%
cases:15.63%
controls:8.03%
cases:27.47%
controls:20.35%
166
1559
381
3892
59
463
488
4988
7
74
540
5377
—
10
53
537
5386
83
422
448
4835
125
911
330
3566
Routine postpartum follow-up
Z39.2 [45547306]
4.1e-01
5.8e-01
-1.0e+50
—
-1.0e+50
1.1e+00
5.4e-01
cases:4.94%
controls:3.34%
cases:1.83%
controls:1.03%
cases:0.00%
controls:0.20%
—
—
cases:0.00%
controls:0.13%
cases:3.58%
controls:1.18%
cases:6.15%
controls:3.66%
27
182
520
5269
10
56
537
5395
0
11
547
5440
—
0
7
547
5432
19
62
512
5195
28
164
427
4313
FEV1
20150-9 [3024653]
4.9e-01
1.2e+00
—
—
—
1.3e+00
1.1e+00
cases:2.74%
controls:1.71%
cases:1.65%
controls:0.51%
—
—
—
—
—
—
cases:1.32%
controls:0.38%
cases:2.86%
controls:0.94%
15
93
532
5358
9
28
538
5423
—
—
—
7
20
524
5237
13
42
442
4435
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
4.9e-01
1.2e+00
—
—
—
1.3e+00
1.1e+00
cases:2.74%
controls:1.71%
cases:1.65%
controls:0.51%
—
—
—
—
—
—
cases:1.32%
controls:0.38%
cases:2.86%
controls:0.94%
15
93
532
5358
9
28
538
5423
—
—
—
7
20
524
5237
13
42
442
4435
FEV1/FVC
19926-5 [3011505]
4.9e-01
1.2e+00
—
—
—
1.3e+00
1.1e+00
cases:2.74%
controls:1.71%
cases:1.65%
controls:0.51%
—
—
—
—
—
—
cases:1.32%
controls:0.38%
cases:2.86%
controls:0.94%
15
93
532
5358
9
28
538
5423
—
—
—
7
20
524
5237
13
42
442
4435
zolpidem; oral
N05CF02 [21604655]
3.7e-01
7.1e-01
1.0e+00
—
1.5e+00
1.1e+00
5.1e-01
cases:3.84%
controls:2.68%
cases:3.11%
controls:1.56%
cases:0.91%
controls:0.33%
—
—
cases:1.10%
controls:0.26%
cases:3.39%
controls:1.12%
cases:4.84%
controls:2.97%
21
146
526
5305
17
85
530
5366
5
18
542
5433
—
6
14
541
5425
18
59
513
5198
22
133
433
4344
letrozole; oral
L02BG04 [21603842]
4.9e-01
—
—
—
-1.0e+50
2.4e-01
1.1e+00
cases:1.46%
controls:0.90%
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:0.94%
controls:0.74%
cases:3.30%
controls:1.09%
8
49
539
5402
—
—
—
0
7
547
5432
5
39
526
5218
15
49
440
4428
Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
93769-8 [1002102]
5.7e-01
—
—
—
—
9.6e-01
1.1e+00
cases:1.65%
controls:0.94%
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.36%
cases:2.86%
controls:0.96%
9
51
538
5400
—
—
—
—
5
19
526
5238
13
43
442
4434
dexrabeprazole
A02BC07 [45893509]
1.1e+00
7.4e-01
—
—
—
—
1.0e+00
cases:2.56%
controls:0.88%
cases:0.91%
controls:0.44%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.89%
14
48
533
5403
5
24
542
5427
—
—
—
—
11
40
444
4437
rabeprazole; oral
A02BC04 [21600099]
1.1e+00
7.4e-01
—
—
—
—
1.0e+00
cases:2.56%
controls:0.88%
cases:0.91%
controls:0.44%
—
—
—
—
—
—
—
—
cases:2.42%
controls:0.89%
14
48
533
5403
5
24
542
5427
—
—
—
—
11
40
444
4437
Respiratory and circulatory monitoring
WX700 [2001310817]
1.2e-01
1.3e+00
—
—
—
—
1.1e+00
cases:1.83%
controls:1.63%
cases:0.91%
controls:0.26%
—
—
—
—
—
—
—
—
cases:3.74%
controls:1.32%
10
89
537
5362
5
14
542
5437
—
—
—
—
17
59
438
4418
Cathetrisation of vein
TPH04 [2001309597]
3.8e-02
2.4e-01
—
—
—
3.5e-01
1.0e+00
cases:2.74%
controls:2.64%
cases:1.10%
controls:0.86%
—
—
—
—
—
—
cases:1.13%
controls:0.80%
cases:6.59%
controls:2.48%
15
144
532
5307
6
47
541
5404
—
—
—
6
42
525
5215
30
111
425
4366
amoxicillin; oral, parenteral
J01CA04 [21602823]
8.6e-02
5.1e-01
—
—
3.3e-01
5.0e-01
3.5e-01
cases:25.23%
controls:23.65%
cases:10.24%
controls:6.38%
—
—
—
—
cases:1.10%
controls:0.79%
cases:10.73%
controls:6.77%
cases:27.25%
controls:20.88%
138
1289
409
4162
56
348
491
5103
—
—
6
43
541
5396
57
356
474
4901
124
935
331
3542
Audiometric test
21727005 [4071702]
4.5e-01
1.1e+00
—
—
-1.0e+50
—
1.0e+00
cases:2.56%
controls:1.65%
cases:1.10%
controls:0.39%
—
—
—
—
cases:0.00%
controls:0.11%
—
—
cases:3.74%
controls:1.38%
14
90
533
5361
6
21
541
5430
—
—
0
6
547
5433
—
17
62
438
4415
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
-2.7e-01
7.5e-01
—
—
—
1.1e+00
1.0e+00
cases:2.74%
controls:3.56%
cases:1.46%
controls:0.70%
—
—
—
—
—
—
cases:1.32%
controls:0.46%
cases:3.96%
controls:1.50%
15
194
532
5257
8
38
539
5413
—
—
—
7
24
524
5233
18
67
437
4410
glyceryl trinitrate; local oral, oral, sublingual, transdermal
C01DA02 [21600317]
7.9e-01
9.3e-01
—
—
—
1.1e+00
9.9e-01
cases:3.29%
controls:1.52%
cases:2.01%
controls:0.81%
—
—
—
—
—
—
cases:2.26%
controls:0.74%
cases:3.52%
controls:1.34%
18
83
529
5368
11
44
536
5407
—
—
—
12
39
519
5218
16
60
439
4417
Acute maxillary sinusitis
J01.0 [45601112]
-4.0e-01
9.6e-01
—
—
—
-4.2e-01
1.8e-01
cases:2.93%
controls:4.29%
cases:3.11%
controls:1.21%
—
—
—
—
—
—
cases:1.13%
controls:1.71%
cases:6.15%
controls:5.18%
16
234
531
5217
17
66
530
5385
—
—
—
6
90
525
5167
28
232
427
4245
Irrigation or wax removal of outer auditory canal
SPAT1033 [2001700134]
-5.3e-02
—
—
—
-1.0e+50
—
9.5e-01
cases:2.19%
controls:2.31%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:3.96%
controls:1.56%
12
126
535
5325
—
—
—
0
5
547
5434
—
18
70
437
4407
Colonoscopy Study observation
28023-0 [3022145]
5.1e-01
9.5e-01
—
—
—
—
9.4e-01
cases:3.11%
controls:1.89%
cases:1.83%
controls:0.72%
—
—
—
—
—
—
—
—
cases:4.62%
controls:1.85%
17
103
530
5348
10
39
537
5412
—
—
—
—
21
83
434
4394
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
1.8e-01
2.2e-01
—
—
—
9.3e-01
3.2e-01
cases:7.68%
controls:6.49%
cases:3.11%
controls:2.51%
—
—
—
—
—
—
cases:4.52%
controls:1.83%
cases:8.13%
controls:6.03%
42
354
505
5097
17
137
530
5314
—
—
—
24
96
507
5161
37
270
418
4207
Observation for other suspected diseases and conditions
Z03.89 [2000503757]
9.1e-01
8.3e-01
—
—
—
—
3.2e-01
cases:3.84%
controls:1.58%
cases:1.46%
controls:0.64%
—
—
—
—
—
—
—
—
cases:2.64%
controls:1.92%
21
86
526
5365
8
35
539
5416
—
—
—
—
12
86
443
4391
glucosamine; oral
M01AX05 [21604002]
9.1e-01
1.1e+00
—
—
—
5.9e-01
5.3e-01
cases:4.39%
controls:1.82%
cases:1.83%
controls:0.61%
—
—
—
—
—
—
cases:1.69%
controls:0.95%
cases:3.52%
controls:2.10%
24
99
523
5352
10
33
537
5418
—
—
—
9
50
522
5207
16
94
439
4383
Coloscopy
UJF32 [2001305029]
4.3e-01
6.8e-01
—
—
—
—
9.0e-01
cases:4.20%
controls:2.79%
cases:1.65%
controls:0.84%
—
—
—
—
—
—
—
—
cases:5.49%
controls:2.30%
23
152
524
5299
9
46
538
5405
—
—
—
—
25
103
430
4374
Low back symptom/complaint
L03 [2002000628]
4.1e-01
4.3e-02
—
—
-1.0e+50
8.9e-01
3.3e-01
cases:6.22%
controls:4.22%
cases:1.65%
controls:1.58%
—
—
—
—
cases:0.00%
controls:0.24%
cases:3.58%
controls:1.50%
cases:7.47%
controls:5.49%
34
230
513
5221
9
86
538
5365
—
—
0
13
547
5426
19
79
512
5178
34
246
421
4231
Audiology
64 [38004489]
8.9e-01
9.6e-01
—
—
—
1.2e+00
6.5e-01
cases:3.66%
controls:1.54%
cases:1.28%
controls:0.50%
—
—
—
—
—
—
cases:1.69%
controls:0.53%
cases:3.96%
controls:2.10%
20
84
527
5367
7
27
540
5424
—
—
—
9
28
522
5229
18
94
437
4383
Laceration/cut
S18 [2002000983]
6.7e-02
8.3e-01
—
—
—
3.6e-01
7.0e-02
cases:7.13%
controls:6.70%
cases:4.20%
controls:1.87%
—
—
—
—
—
—
cases:3.20%
controls:2.26%
cases:8.57%
controls:8.04%
39
365
508
5086
23
102
524
5349
—
—
—
17
119
514
5138
39
360
416
4117
Spinalanesthesia
WX320 [2001310799]
-2.9e-01
6.5e-01
—
—
—
5.3e-01
8.2e-01
cases:2.19%
controls:2.92%
cases:1.46%
controls:0.77%
—
—
—
—
—
—
cases:1.51%
controls:0.89%
cases:6.15%
controls:2.81%
12
159
535
5292
8
42
539
5409
—
—
—
8
47
523
5210
28
126
427
4351
Pharmacy visit
OMOP4822462 [581458]
6.0e-01
4.1e-01
2.8e-02
8.0e-01
7.4e-02
3.4e-01
3.6e-01
cases:96.71%
controls:94.15%
cases:86.47%
controls:80.99%
cases:40.59%
controls:39.92%
cases:4.39%
controls:2.02%
cases:41.50%
controls:39.71%
cases:86.06%
controls:81.43%
cases:96.26%
controls:94.73%
529
5132
18
319
473
4415
74
1036
222
2176
325
3275
24
110
523
5341
227
2160
320
3279
457
4281
74
976
438
4241
17
236
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
5.0e-01
—
—
—
-1.0e+50
6.8e-01
7.6e-01
cases:4.20%
controls:2.61%
—
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:2.26%
controls:1.16%
cases:7.03%
controls:3.42%
23
142
524
5309
—
—
—
0
12
547
5427
12
61
519
5196
32
153
423
4324
CBC panel - Blood by Automated count
58410-2 [40761511]
1.9e-01
3.0e-01
7.4e-01
—
5.4e-01
3.1e-01
2.6e-01
cases:40.59%
controls:36.09%
cases:26.69%
controls:21.23%
cases:7.50%
controls:3.71%
—
—
cases:4.94%
controls:2.92%
cases:26.74%
controls:21.04%
cases:46.81%
controls:40.50%
222
1967
325
3484
146
1157
401
4294
41
202
506
5249
—
27
159
520
5280
142
1106
389
4151
213
1813
242
2664
fluticasone, combinations
R01AD58 [43534837]
2.4e-01
7.2e-01
—
—
—
4.9e-01
2.2e-01
cases:6.76%
controls:5.39%
cases:5.12%
controls:2.55%
—
—
—
—
—
—
cases:4.33%
controls:2.70%
cases:7.69%
controls:6.28%
37
294
510
5157
28
139
519
5312
—
—
—
23
142
508
5115
35
281
420
4196
Knee symptom/complaint
L15 [2002000639]
7.2e-01
8.7e-02
—
—
—
3.5e-01
1.6e-01
cases:5.48%
controls:2.75%
cases:1.28%
controls:1.17%
—
—
—
—
—
—
cases:1.88%
controls:1.33%
cases:4.40%
controls:3.75%
30
150
517
5301
7
64
540
5387
—
—
—
10
70
521
5187
20
168
435
4309
azelastine; nasal
R01AC03 [21605035]
2.3e-01
7.2e-01
—
—
—
4.9e-01
2.1e-01
cases:6.76%
controls:5.47%
cases:5.12%
controls:2.57%
—
—
—
—
—
—
cases:4.33%
controls:2.70%
cases:7.69%
controls:6.30%
37
298
510
5153
28
140
519
5311
—
—
—
23
142
508
5115
35
282
420
4195
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
2.0e-01
4.5e-01
1.1e+00
—
6.9e-01
6.9e-01
3.8e-01
cases:8.59%
controls:7.17%
cases:4.57%
controls:2.95%
cases:1.28%
controls:0.44%
—
—
cases:1.28%
controls:0.64%
cases:5.84%
controls:3.01%
cases:10.99%
controls:7.80%
47
391
500
5060
25
161
522
5290
7
24
540
5427
—
7
35
540
5404
31
158
500
5099
50
349
405
4128
Otolaryngology
4 [38004449]
3.1e-01
1.7e-01
1.2e+00
—
9.2e-01
6.1e-01
6.8e-01
cases:12.07%
controls:9.12%
cases:4.20%
controls:3.56%
cases:1.28%
controls:0.40%
—
—
cases:1.10%
controls:0.44%
cases:5.46%
controls:3.04%
cases:16.26%
controls:8.93%
66
497
481
4954
23
194
524
5257
7
22
540
5429
—
6
24
541
5415
29
160
502
5097
74
400
381
4077
Outpatient Hospital
22 [8756]
5.1e-02
4.4e-01
—
—
1.1e+00
6.8e-01
2.9e-01
cases:21.94%
controls:21.08%
cases:7.13%
controls:4.71%
—
—
—
—
cases:1.28%
controls:0.44%
cases:8.85%
controls:4.68%
cases:16.70%
controls:13.09%
120
1149
427
4302
39
257
508
5194
—
—
7
24
540
5415
47
246
484
5011
76
586
379
3891
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
3.6e-01
4.9e-01
—
—
—
7.3e-01
6.7e-01
cases:5.85%
controls:4.15%
cases:3.47%
controls:2.16%
—
—
—
—
—
—
cases:3.58%
controls:1.75%
cases:10.99%
controls:5.96%
32
226
515
5225
19
118
528
5333
—
—
—
19
92
512
5165
50
267
405
4210
Thorax X-ray examination
GD1AA [2001303617]
1.2e-01
3.1e-02
—
—
—
7.0e-01
6.4e-01
cases:6.58%
controls:5.87%
cases:2.19%
controls:2.13%
—
—
—
—
—
—
cases:4.14%
controls:2.11%
cases:10.33%
controls:5.72%
36
320
511
5131
12
116
535
5335
—
—
—
22
111
509
5146
47
256
408
4221
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-1.5e-01
4.5e-01
5.8e-01
—
1.2e+00
4.9e-01
6.2e-01
cases:6.76%
controls:7.76%
cases:5.67%
controls:3.71%
cases:0.91%
controls:0.51%
—
—
cases:1.65%
controls:0.51%
cases:5.46%
controls:3.42%
cases:16.48%
controls:9.58%
37
423
510
5028
31
202
516
5249
5
28
542
5423
—
9
28
538
5411
29
180
502
5077
75
429
380
4048
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-8.2e-02
4.8e-01
—
—
—
1.8e-01
6.0e-01
cases:7.86%
controls:8.48%
cases:2.93%
controls:1.83%
—
—
—
—
—
—
cases:2.07%
controls:1.73%
cases:10.33%
controls:5.92%
43
462
504
4989
16
100
531
5351
—
—
—
11
91
520
5166
47
265
408
4212
Emergency Room Visit
ER [9203]
2.3e-01
2.5e-01
3.4e-01
—
8.7e-01
5.8e-01
2.9e-01
cases:37.48%
controls:32.21%
cases:12.80%
controls:10.29%
cases:1.83%
controls:1.30%
—
—
cases:2.38%
controls:1.01%
cases:14.69%
controls:8.79%
cases:31.65%
controls:25.78%
205
1756
342
3695
70
561
477
4890
10
71
537
5380
—
13
55
534
5384
78
462
453
4795
144
1154
311
3323
Orthopedic Surgery
20 [38004465]
-5.0e-02
4.0e-01
2.6e-01
—
5.8e-01
5.8e-01
1.1e-01
cases:12.07%
controls:12.60%
cases:6.76%
controls:4.64%
cases:1.10%
controls:0.84%
—
—
cases:1.46%
controls:0.83%
cases:8.47%
controls:4.95%
cases:14.07%
controls:12.78%
66
687
481
4764
37
253
510
5198
6
46
541
5405
—
8
45
539
5394
45
260
486
4997
64
572
391
3905
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
3.3e-01
3.1e-01
8.5e-01
—
1.1e+00
5.0e-01
5.7e-01
cases:13.53%
controls:10.07%
cases:6.58%
controls:4.92%
cases:1.83%
controls:0.79%
—
—
cases:2.01%
controls:0.68%
cases:7.53%
controls:4.70%
cases:19.12%
controls:11.79%
74
549
473
4902
36
268
511
5183
10
43
537
5408
—
11
37
536
5402
40
247
491
5010
87
528
368
3949
INR in Blood by Coagulation assay
34714-6 [3032080]
1.3e-03
3.7e-01
6.0e-01
—
4.7e-01
3.2e-01
5.7e-01
cases:7.86%
controls:7.85%
cases:5.30%
controls:3.71%
cases:1.46%
controls:0.81%
—
—
cases:1.46%
controls:0.92%
cases:3.95%
controls:2.89%
cases:14.07%
controls:8.51%
43
428
504
5023
29
202
518
5249
8
44
539
5407
—
8
50
539
5389
21
152
510
5105
64
381
391
4096
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
3.0e-01
6.7e-02
—
—
—
1.4e-01
5.6e-01
cases:7.86%
controls:5.96%
cases:2.74%
controls:2.57%
—
—
—
—
—
—
cases:2.45%
controls:2.13%
cases:11.43%
controls:6.83%
43
325
504
5126
15
140
532
5311
—
—
—
13
112
518
5145
52
306
403
4171
MCH [Entitic mass]
28539-5 [3035941]
8.5e-02
1.5e-01
5.5e-01
—
2.4e-01
3.0e-01
1.3e-01
cases:44.97%
controls:42.89%
cases:35.65%
controls:32.27%
cases:11.33%
controls:6.86%
—
—
cases:7.31%
controls:5.87%
cases:39.55%
controls:32.62%
cases:56.48%
controls:53.23%
246
2338
301
3113
195
1759
352
3692
62
374
485
5077
—
40
319
507
5120
210
1715
321
3542
257
2383
198
2094
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
8.4e-02
1.5e-01
5.5e-01
—
2.4e-01
3.0e-01
1.3e-01
cases:44.97%
controls:42.91%
cases:35.65%
controls:32.31%
cases:11.33%
controls:6.88%
—
—
cases:7.31%
controls:5.85%
cases:39.55%
controls:32.70%
cases:56.48%
controls:53.27%
246
2339
301
3112
195
1761
352
3690
62
375
485
5076
—
40
318
507
5121
210
1719
321
3538
257
2385
198
2092
Leukocytes [#/volume] in Blood
26464-8 [3010813]
9.0e-02
1.5e-01
5.5e-01
—
2.3e-01
3.0e-01
1.3e-01
cases:45.16%
controls:42.93%
cases:35.65%
controls:32.32%
cases:11.33%
controls:6.88%
—
—
cases:7.31%
controls:5.92%
cases:39.55%
controls:32.72%
cases:56.48%
controls:53.34%
247
2340
300
3111
195
1762
352
3689
62
375
485
5076
—
40
322
507
5117
210
1720
321
3537
257
2388
198
2089
Platelets [#/volume] in Blood
26515-7 [3007461]
6.4e-02
1.4e-01
5.5e-01
—
2.4e-01
3.0e-01
1.3e-01
cases:44.42%
controls:42.85%
cases:35.47%
controls:32.31%
cases:11.33%
controls:6.88%
—
—
cases:7.31%
controls:5.83%
cases:39.55%
controls:32.59%
cases:56.48%
controls:53.16%
243
2336
304
3115
194
1761
353
3690
62
375
485
5076
—
40
317
507
5122
210
1713
321
3544
257
2380
198
2097
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
8.5e-02
1.5e-01
5.5e-01
—
2.4e-01
3.0e-01
1.3e-01
cases:44.97%
controls:42.89%
cases:35.65%
controls:32.29%
cases:11.33%
controls:6.88%
—
—
cases:7.31%
controls:5.85%
cases:39.55%
controls:32.64%
cases:56.48%
controls:53.23%
246
2338
301
3113
195
1760
352
3691
62
375
485
5076
—
40
318
507
5121
210
1716
321
3541
257
2383
198
2094
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
8.0e-02
1.4e-01
5.5e-01
—
2.3e-01
3.0e-01
1.4e-01
cases:44.97%
controls:43.00%
cases:35.65%
controls:32.42%
cases:11.33%
controls:6.90%
—
—
cases:7.31%
controls:5.90%
cases:39.74%
controls:32.76%
cases:56.92%
controls:53.43%
246
2344
301
3107
195
1767
352
3684
62
376
485
5075
—
40
321
507
5118
211
1722
320
3535
259
2392
196
2085
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
8.3e-02
1.5e-01
5.5e-01
—
2.4e-01
3.0e-01
1.3e-01
cases:44.97%
controls:42.93%
cases:35.65%
controls:32.32%
cases:11.33%
controls:6.90%
—
—
cases:7.31%
controls:5.87%
cases:39.55%
controls:32.68%
cases:56.48%
controls:53.27%
246
2340
301
3111
195
1762
352
3689
62
376
485
5075
—
40
319
507
5120
210
1718
321
3539
257
2385
198
2092
Differential panel, method unspecified - Blood
69738-3 [42870588]
2.8e-01
4.4e-01
5.0e-01
—
8.2e-01
5.1e-01
5.4e-01
cases:9.32%
controls:7.19%
cases:6.03%
controls:3.98%
cases:1.65%
controls:1.01%
—
—
cases:1.28%
controls:0.57%
cases:6.40%
controls:3.94%
cases:13.41%
controls:8.24%
51
392
496
5059
33
217
514
5234
9
55
538
5396
—
7
31
540
5408
34
207
497
5050
61
369
394
4108
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-1.5e-01
4.5e-01
5.1e-01
—
1.0e+00
3.8e-01
5.4e-01
cases:7.50%
controls:8.57%
cases:6.58%
controls:4.31%
cases:1.10%
controls:0.66%
—
—
cases:1.65%
controls:0.61%
cases:6.03%
controls:4.20%
cases:18.02%
controls:11.39%
41
467
506
4984
36
235
511
5216
6
36
541
5415
—
9
33
538
5406
32
221
499
5036
82
510
373
3967
azithromycin; oral, parenteral
J01FA10 [21602978]
3.7e-01
4.5e-01
—
—
—
2.8e-01
5.4e-01
cases:13.71%
controls:9.89%
cases:3.47%
controls:2.24%
—
—
—
—
—
—
cases:3.01%
controls:2.30%
cases:11.87%
controls:7.30%
75
539
472
4912
19
122
528
5329
—
—
—
16
121
515
5136
54
327
401
4150
Health maint/preventive medicine
A98 [2002000231]
9.6e-02
2.1e-01
5.3e-01
-1.0e+50
7.6e-02
1.7e-01
7.1e-02
cases:46.98%
controls:44.60%
cases:36.01%
controls:31.30%
cases:9.32%
controls:5.71%
cases:0.00%
controls:0.33%
cases:6.95%
controls:6.47%
cases:35.97%
controls:32.15%
cases:55.82%
controls:54.08%
257
2431
290
3020
197
1706
350
3745
51
311
496
5140
0
18
547
5433
38
352
509
5087
191
1690
340
3567
254
2421
201
2056
Counselling related to known health issue
SPAT1310 [2001700411]
5.2e-01
5.7e-01
—
—
—
3.9e-01
3.3e-01
cases:10.60%
controls:6.57%
cases:2.93%
controls:1.67%
—
—
—
—
—
—
cases:2.26%
controls:1.54%
cases:6.37%
controls:4.67%
58
358
489
5093
16
91
531
5360
—
—
—
12
81
519
5176
29
209
426
4268
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
5.4e-02
5.2e-01
8.4e-01
—
4.5e-01
4.9e-01
3.4e-01
cases:10.42%
controls:9.92%
cases:10.24%
controls:6.35%
cases:2.01%
controls:0.88%
—
—
cases:1.10%
controls:0.70%
cases:9.42%
controls:5.99%
cases:21.76%
controls:16.55%
57
541
490
4910
56
346
491
5105
11
48
536
5403
—
6
38
541
5401
50
315
481
4942
99
741
356
3736
esomeprazole; oral, parenteral
A02BC05 [21600100]
5.0e-01
4.4e-01
1.3e-01
—
8.6e-01
4.7e-01
4.3e-01
cases:10.60%
controls:6.71%
cases:5.30%
controls:3.47%
cases:0.91%
controls:0.81%
—
—
cases:1.46%
controls:0.63%
cases:5.65%
controls:3.61%
cases:10.33%
controls:6.95%
58
366
489
5085
29
189
518
5262
5
44
542
5407
—
8
34
539
5405
30
190
501
5067
47
311
408
4166
doxycycline; oral, parenteral
J01AA02 [21602800]
2.3e-01
2.1e-01
—
—
—
4.3e-02
4.8e-01
cases:19.01%
controls:15.72%
cases:5.12%
controls:4.18%
—
—
—
—
—
—
cases:4.14%
controls:3.98%
cases:19.56%
controls:13.07%
104
857
443
4594
28
228
519
5223
—
—
—
22
209
509
5048
89
585
366
3892
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
1.7e-01
3.2e-01
9.8e-01
—
—
3.1e-01
4.8e-01
cases:13.89%
controls:11.96%
cases:6.95%
controls:5.16%
cases:1.65%
controls:0.62%
—
—
—
—
cases:6.03%
controls:4.49%
cases:21.98%
controls:14.90%
76
652
471
4799
38
281
509
5170
9
34
538
5417
—
—
32
236
499
5021
100
667
355
3810
combinations of corticosteroids
D07XB30 [21602188]
4.4e-01
4.3e-01
—
—
—
5.2e-01
1.9e-01
cases:14.81%
controls:10.05%
cases:5.12%
controls:3.38%
—
—
—
—
—
—
cases:5.27%
controls:3.21%
cases:11.65%
controls:9.81%
81
548
466
4903
28
184
519
5267
—
—
—
28
169
503
5088
53
439
402
4038
combinations of corticosteroids
D07AB30 [21602118]
4.4e-01
4.3e-01
—
—
—
5.2e-01
1.9e-01
cases:14.81%
controls:10.05%
cases:5.12%
controls:3.38%
—
—
—
—
—
—
cases:5.27%
controls:3.21%
cases:11.65%
controls:9.81%
81
548
466
4903
28
184
519
5267
—
—
—
28
169
503
5088
53
439
402
4038
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
2.5e-01
—
—
—
-1.0e+50
7.8e-01
1.5e-02
cases:1.46%
controls:1.14%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:1.32%
controls:0.61%
cases:2.20%
controls:2.17%
8
62
539
5389
—
—
—
0
5
547
5434
7
32
524
5225
10
97
445
4380
Alcohol-related acute intoxication uncomplicated
F10.00 [2000501668]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
0
5
547
5446
—
—
—
—
—
0
7
455
4470
ethinylestradiol; oral
G03CA01 [21602516]
—
—
-1.0e+50
—
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
5
547
5446
—
0
7
547
5432
—
—
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
-2.7e-01
—
—
—
—
1.8e-01
1.4e-01
cases:2.74%
controls:3.56%
—
—
—
—
—
—
—
—
cases:1.51%
controls:1.26%
cases:4.84%
controls:4.22%
15
194
532
5257
—
—
—
—
8
66
523
5191
22
189
433
4288
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 [2002330110]
-5.2e-01
3.6e-01
—
—
—
—
1.0e+50
cases:2.38%
controls:3.94%
cases:1.28%
controls:0.90%
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.00%
13
215
534
5236
7
49
540
5402
—
—
—
—
7
0
448
4477
Flexible bronchoscopy
UGC12 [2001303610]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
0
6
531
5251
—
Abnormal blood-pressure reading, without diagnosis
R03 [45755625]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
6
455
4471
Blockage of nerv root with CT guidance
AB5CT [2001300533]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Pleural effusion, not elsewhere classified
J90 [45605897]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
0
8
547
5443
—
—
—
—
—
0
6
455
4471
Timothy IgE Ab [Units/volume] in Serum
6265-3 [3003888]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
—
—
—
0
10
547
5441
—
—
—
0
10
531
5247
—
Calculus of gallbladder without cholecystitis
K80.2 [45552951]
8.2e-01
—
—
—
—
-1.0e+50
6.9e-01
cases:2.01%
controls:0.90%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
cases:1.76%
controls:0.89%
11
49
536
5402
—
—
—
—
0
8
531
5249
8
40
447
4437
sulfasalazine; oral, rectal
A07EC01 [21600663]
-2.8e-01
8.1e-02
—
—
-1.0e+50
—
—
cases:1.10%
controls:1.45%
cases:0.91%
controls:0.84%
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
6
79
541
5372
5
46
542
5405
—
—
0
14
547
5425
—
—
Dog dander IgE Ab [Units/volume] in Serum
6098-8 [3014133]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
0
6
547
5445
—
—
—
0
9
531
5248
—
Erysipelas
A46 [45561706]
—
-1.0e+50
—
—
—
—
2.4e-01
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
cases:2.20%
controls:1.74%
—
0
23
547
5428
—
—
—
—
10
78
445
4399
Apolipoprotein B/Apolipoprotein A-I [Percentile]
9340-1 [3011831]
—
—
—
—
—
-1.0e+50
1.4e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:1.10%
controls:0.96%
—
—
—
—
—
0
10
531
5247
5
43
450
4434
Stenosis and insufficiency of lacrimal passages
H04.5 [45581556]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
547
5440
—
—
—
—
—
—
benzylpenicillin; parenteral
J01CE01 [21602841]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Preparation for dental prosthetics
SPA02 [2001310460]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
547
5444
—
—
—
—
—
—
exenatide; parenteral
A10BJ01 [1123633]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
calcium (different salts in combination); oral
A12AA20 [21600872]
8.4e-02
3.0e-01
-3.5e-03
-1.0e+50
-5.2e-01
2.2e-01
2.4e-01
cases:6.22%
controls:5.74%
cases:6.03%
controls:4.53%
cases:1.10%
controls:1.10%
cases:0.00%
controls:0.13%
cases:0.91%
controls:1.53%
cases:6.21%
controls:5.06%
cases:9.01%
controls:7.26%
34
313
513
5138
33
247
514
5204
6
60
541
5391
0
7
547
5444
5
83
542
5356
33
266
498
4991
41
325
414
4152
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
-1.3e-01
—
-1.0e+50
—
—
—
-3.4e-01
cases:2.56%
controls:2.92%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:2.20%
controls:3.06%
14
159
533
5292
—
0
5
547
5446
—
—
—
10
137
445
4340
Planned therapy visit for psychiatric disease
W0A12 [2001310894]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
sodium fluoride; oral
A01AA01 [21600005]
-3.9e-01
—
-1.0e+50
—
—
—
7.5e-01
cases:0.91%
controls:1.34%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:2.20%
controls:1.05%
5
73
542
5378
—
0
6
547
5445
—
—
—
10
47
445
4430
Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14361-0 [3000855]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.56%
—
0
8
547
5443
—
—
—
0
9
531
5248
0
25
455
4452
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
1.4e-01
—
—
—
—
—
2.8e-01
cases:1.10%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:1.16%
6
52
541
5399
—
—
—
—
—
7
52
448
4425
Benign tumor of the meninges on the outer surface of the cerebrum
D32.00 [2000501307]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
0
8
455
4469
ergotamine; inhalant, oral, parenteral, rectal, sublingual
N02CA02 [21604367]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
547
5444
—
—
—
—
—
—
Benign neoplasm: Transverse colon
D12.3 [45581282]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
547
5443
—
—
—
—
—
—
Hepatitis A virus Ab [Presence] in Serum
20575-7 [3016650]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
15
455
4462
Malignancy NOS
A79 [2002000213]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
0
5
531
5252
—
Intramural leiomyoma of uterus
D25.1 [45547585]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
15
455
4462
valsartan, amlodipine and hydrochlorothiazide
C09DX01 [21601846]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.20%
—
—
—
—
—
0
6
531
5251
0
9
455
4468
Unspecified injury of shoulder and upper arm
S49.9 [45588163]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Osteoporosis, unspecified
M81.9 [45591963]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
0
8
547
5443
—
—
—
—
—
Lupus anticoagulant assay
63300003 [4268621]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
Vision screening
408760009 [4237318]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
Testosterone Free [Moles/volume] in Serum or Plasma by calculation
96559-0 [36032269]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.33%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
18
547
5433
0
5
547
5446
—
—
—
—
—
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 [3007449]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
I80.29 [2000502545]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.22%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
0
12
547
5439
0
7
547
5444
—
—
—
—
—
Other specified diseases of anus and rectum
K62.8 [45581907]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
—
X-ray mammography
HA1AA [2001303884]
—
—
—
—
—
—
9.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.54%
—
—
—
—
—
—
6
24
449
4453
benzathine benzylpenicillin; parenteral
J01CE08 [21602848]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Antenatal classes
SPAT1195 [2001700296]
4.8e-01
—
—
—
—
—
—
cases:1.10%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
—
—
6
37
541
5414
—
—
—
—
—
—
Sprain and strain of shoulder joint
S43.4 [45607418]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
0
7
547
5444
—
—
—
0
5
531
5252
—
Local application of medicine to mouth
SXA20 [2001310579]
8.1e-02
—
—
—
—
—
6.4e-01
cases:0.91%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.58%
5
46
542
5405
—
—
—
—
—
5
26
450
4451
prednisone
A07EA03 [21600655]
-1.5e-01
-1.0e+50
—
—
—
—
—
cases:0.91%
controls:1.06%
cases:0.00%
controls:0.39%
—
—
—
—
—
—
—
—
—
—
5
58
542
5393
0
21
547
5430
—
—
—
—
—
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Asthma, unspecified
J45.9 [45562456]
7.2e-02
6.0e-01
—
—
-1.0e+50
5.6e-01
1.9e-01
cases:3.11%
controls:2.90%
cases:2.01%
controls:1.12%
—
—
—
—
cases:0.00%
controls:0.20%
cases:2.07%
controls:1.20%
cases:4.40%
controls:3.66%
17
158
530
5293
11
61
536
5390
—
—
0
11
547
5428
11
63
520
5194
20
164
435
4313
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
-1.8e-01
7.3e-01
—
—
—
1.0e+00
4.0e-01
cases:1.46%
controls:1.74%
cases:1.10%
controls:0.53%
—
—
—
—
—
—
cases:1.88%
controls:0.68%
cases:3.30%
controls:2.23%
8
95
539
5356
6
29
541
5422
—
—
—
10
36
521
5221
15
100
440
4377
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y84 [45605063]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
—
Exposure to unspecified factor
X59 [45756412]
2.0e-02
—
-1.0e+50
—
—
3.8e-01
3.7e-01
cases:2.38%
controls:2.33%
—
—
cases:0.00%
controls:0.09%
—
—
—
—
cases:0.94%
controls:0.65%
cases:3.30%
controls:2.30%
13
127
534
5324
—
0
5
547
5446
—
—
5
34
526
5223
15
103
440
4374
Leukocytes [#/volume] in Pleural fluid
26467-1 [3023199]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Ehlers-Danlos syndrome
Q79.6 [45587483]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
—
0
16
547
5435
—
—
—
—
—
Venereal disease screening
171128005 [4064905]
-6.9e-02
—
—
—
—
—
—
cases:1.10%
controls:1.17%
—
—
—
—
—
—
—
—
—
—
—
—
6
64
541
5387
—
—
—
—
—
—
Twin pregnancy with separate amniotic and chorionic sacs
O30.00 [2000503212]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
547
5444
—
—
—
—
—
—
Cervical spine MRI examination with high intensity magnet
NA1BG [2001306990]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
0
8
547
5443
—
—
—
0
6
531
5251
—
Other administrative function
SPAT1281 [2001700382]
—
—
—
—
—
—
9.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.54%
—
—
—
—
—
—
6
24
449
4453
Type 1 diabetes mellitus, With ketoacidosis
E10.1 [45542735]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.40%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
0
22
547
5429
0
7
547
5444
—
—
—
—
0
14
455
4463
estriol; oral, parenteral, vaginal
G03CA04 [21602518]
8.7e-01
—
—
—
—
—
—
cases:1.83%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
—
—
10
42
537
5409
—
—
—
—
—
—
cefadroxil; oral
J01DB05 [21602874]
5.0e-01
-1.0e+50
—
—
—
-1.0e+50
7.2e-01
cases:2.19%
controls:1.34%
cases:0.00%
controls:0.29%
—
—
—
—
—
—
cases:0.00%
controls:0.19%
cases:1.10%
controls:0.54%
12
73
535
5378
0
16
547
5435
—
—
—
0
10
531
5247
5
24
450
4453
Pterygium
H11.0 [45586365]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
—
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
Resting ECG, 12 leads
FP1B5 [2001303119]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.18%
cases:0.00%
controls:0.17%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
0
10
547
5441
0
9
547
5442
—
—
—
0
6
531
5251
—
Angina pectoris, unspecified
I20.99 [2000502407]
—
-1.0e+50
—
—
—
—
1.6e+00
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.22%
—
0
7
547
5444
—
—
—
—
5
10
450
4467
Diabetic background retinopathy
H36.00 [2000502320]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
0
8
547
5443
0
5
547
5446
—
—
—
—
0
12
455
4465
anastrozole; oral
L02BG03 [21603841]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.13%
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.27%
0
9
547
5442
0
7
547
5444
—
—
—
0
9
531
5248
0
12
455
4465
Other specified disorders of nose and nasal sinuses
J34.8 [45576947]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
6
455
4471
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.18%
—
0
5
547
5446
—
—
—
0
6
531
5251
0
8
455
4469
Atypical anorexia nervosa
F50.1 [45586245]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
finasteride; oral
G04CB01 [21602675]
—
—
—
—
—
—
4.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.83%
—
—
—
—
—
—
6
37
449
4440
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
-4.2e-02
4.3e-01
9.2e-01
—
1.2e+00
2.2e-01
2.2e-01
cases:8.23%
controls:8.55%
cases:5.48%
controls:3.63%
cases:1.28%
controls:0.51%
—
—
cases:1.83%
controls:0.55%
cases:4.71%
controls:3.80%
cases:11.65%
controls:9.60%
45
466
502
4985
30
198
517
5253
7
28
540
5423
—
10
30
537
5409
25
200
506
5057
53
430
402
4047
Burn-out
Z73.0 [45576177]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
0
11
531
5246
—
rivastigmine; oral, transdermal
N06DA03 [21604796]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
—
Gonarthrosis, unspecified
M17.9 [45606128]
3.0e-01
—
—
—
—
—
-1.3e-01
cases:1.28%
controls:0.95%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:1.25%
7
52
540
5399
—
—
—
—
—
5
56
450
4421
Paroxysmal atrial fibrillation
I48.0 [45581776]
—
-1.0e+50
—
—
—
—
3.9e-01
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.89%
—
0
18
547
5433
—
—
—
—
6
40
449
4437
Rheumatoid arthritis, unspecified
M06.9 [45533705]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
0
7
547
5444
—
—
—
—
—
Extensive health check-up on first grade
SPAT1384 [2001700484]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
0
10
547
5441
—
—
—
—
—
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
F10.2 [45576496]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
mometasone; nasal
R01AD09 [21605051]
-8.7e-02
3.7e-01
—
—
—
-3.8e-01
2.5e-01
cases:8.59%
controls:9.30%
cases:5.30%
controls:3.72%
—
—
—
—
—
—
cases:2.64%
controls:3.82%
cases:12.09%
controls:9.67%
47
507
500
4944
29
203
518
5248
—
—
—
14
201
517
5056
55
433
400
4044
Primary total prosthetic replacement of hip joint not using cement
NFB30 [2001307921]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
—
—
—
—
—
—
0
28
547
5423
—
—
—
—
—
—
Nursing episode
950 [44777714]
-1.0e+50
—
-1.0e+50
—
-1.0e+50
—
—
cases:0.00%
controls:0.62%
—
—
cases:0.00%
controls:0.11%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
0
34
547
5417
—
0
6
547
5445
—
0
7
547
5432
—
—
Overall medication plan or its review
SPAT1252 [2001700353]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
0
9
547
5442
—
—
—
—
—
Other abnormal findings on antenatal screening of mother
O28.8 [45548729]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
Bronchiectasis
J47 [45605889]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
0
8
547
5443
0
6
547
5445
—
—
—
—
0
8
455
4469
fludrocortisone and antiinfectives
S03CA05 [21605209]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:0.00%
controls:0.11%
—
0
6
547
5445
—
—
—
0
5
531
5252
0
5
455
4472
Unspecified lump in breast
N63 [45601743]
7.0e-01
—
—
—
—
—
4.3e-01
cases:1.28%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:1.01%
7
35
540
5416
—
—
—
—
—
7
45
448
4432
Vancomycin [Susceptibility]
19000-9 [3014271]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
—
0
38
547
5413
—
—
—
—
—
Administration of medicine
SPAT1254 [2001700355]
-2.6e-01
9.6e-01
-1.0e+50
-1.0e+50
-1.0e+50
—
-9.8e-02
cases:1.46%
controls:1.89%
cases:1.28%
controls:0.50%
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.09%
cases:0.00%
controls:0.22%
—
—
cases:1.32%
controls:1.45%
8
103
539
5348
7
27
540
5424
0
14
547
5437
0
5
547
5446
0
12
547
5427
—
6
65
449
4412
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 [3013603]
9.4e-02
-2.1e-01
1.2e+00
—
—
4.8e-01
2.8e-01
cases:3.66%
controls:3.34%
cases:1.83%
controls:2.26%
cases:1.28%
controls:0.40%
—
—
—
—
cases:3.39%
controls:2.13%
cases:6.37%
controls:4.89%
20
182
527
5269
10
123
537
5328
7
22
540
5429
—
—
18
112
513
5145
29
219
426
4258
Right side
ZXA00 [2001311346]
-5.5e-01
—
—
—
—
—
—
cases:1.46%
controls:2.51%
—
—
—
—
—
—
—
—
—
—
—
—
8
137
539
5314
—
—
—
—
—
—
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-8.3e-02
2.5e-01
—
—
—
-1.8e-02
1.9e-01
cases:5.67%
controls:6.13%
cases:3.47%
controls:2.73%
—
—
—
—
—
—
cases:2.45%
controls:2.49%
cases:8.79%
controls:7.39%
31
334
516
5117
19
149
528
5302
—
—
—
13
131
518
5126
40
331
415
4146
Conductive hearing loss, bilateral
H90.0 [45605765]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
0
6
547
5445
—
—
—
—
—
0
5
455
4472
naproxen; oral, rectal
M01AE02 [21603968]
7.3e-02
2.3e-01
—
—
—
1.5e-01
2.7e-01
cases:11.88%
controls:11.14%
cases:5.12%
controls:4.09%
—
—
—
—
—
—
cases:4.33%
controls:3.77%
cases:11.65%
controls:9.18%
65
607
482
4844
28
223
519
5228
—
—
—
23
198
508
5059
53
411
402
4066
Patch test
41778007 [4218642]
—
—
—
—
—
—
9.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.42%
—
—
—
—
—
—
5
19
450
4458
Enthesopathy of lower limb, unspecified
M76.9 [45538865]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
547
5445
—
—
—
—
—
—
Labeling mammary gland pathology with ultrasound guidance
HA4AT [2001303990]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
fluticasone furoate
R03BA09 [45893496]
6.0e-01
5.1e-01
—
—
-1.0e+50
1.5e-01
2.1e-01
cases:4.75%
controls:2.66%
cases:1.83%
controls:1.10%
—
—
—
—
cases:0.00%
controls:0.29%
cases:1.32%
controls:1.14%
cases:3.30%
controls:2.68%
26
145
521
5306
10
60
537
5391
—
—
0
16
547
5423
7
60
524
5197
15
120
440
4357
Heart failure, unspecified
I50.9 [45576879]
—
-1.0e+50
—
—
-1.0e+50
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
0
20
547
5431
—
—
0
5
547
5434
—
—
Reparation of dental prosthesis without impressions
SPF00 [2001310544]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
0
9
547
5442
0
5
547
5446
—
—
—
—
—
Prolonged first stage (of labour)
O63.0 [45563158]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
0
6
531
5251
—
10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
48348-7 [3048469]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Bitten or stung by nonvenomous insect and other nonvenomous arthropods
W57 [45756308]
—
—
—
—
—
—
8.6e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.47%
—
—
—
—
—
—
5
21
450
4456
Chronic pansinusitis
J32.4 [45581854]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
547
5443
—
—
—
—
—
—
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.7e-01
6.9e-01
—
—
—
1.9e-01
5.1e-01
cases:3.84%
controls:3.25%
cases:2.74%
controls:1.39%
—
—
—
—
—
—
cases:1.69%
controls:1.41%
cases:5.71%
controls:3.51%
21
177
526
5274
15
76
532
5375
—
—
—
9
74
522
5183
26
157
429
4320
Infected finger/toe
S09 [2002000974]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.17%
cases:0.00%
controls:0.18%
—
—
—
—
—
0
9
531
5248
0
8
455
4469
Hearing loss, unspecified
H91.9 [45547996]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.33%
—
—
—
—
—
—
—
—
—
—
—
—
0
18
547
5433
—
—
—
—
—
—
magnesium hydroxide; oral
A02AA04 [21600052]
—
-1.0e+50
-1.0e+50
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.15%
cases:0.00%
controls:0.13%
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
0
8
547
5443
0
7
547
5444
—
—
0
6
531
5251
—
Otitis externa, unspecified
H60.9 [45605727]
-3.5e-03
—
—
—
—
—
—
cases:0.91%
controls:0.92%
—
—
—
—
—
—
—
—
—
—
—
—
5
50
542
5401
—
—
—
—
—
—
Bacteria identified in Stool by Culture
625-4 [3025941]
-1.0e-01
—
—
—
—
—
3.9e-01
cases:0.91%
controls:1.01%
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:1.05%
5
55
542
5396
—
—
—
—
—
7
47
448
4430
Algoneurodystrophy
M89.0 [45548604]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
0
7
455
4470
Acute subendocardial infarction stenosed coronary artery
I21.41 [2000502433]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
7.8e-01
—
—
—
—
—
—
cases:0.91%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
5
23
542
5428
—
—
—
—
—
—
flupentixol; oral, parenteral
N05AF01 [21604531]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Other health check-up
SPAT1370 [2001700471]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
0
5
531
5252
—
Skin injury other
S19 [2002000984]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.27%
—
—
—
—
—
—
0
12
455
4465
Mouth/tongue/lip symptom/complaint
D20 [2002000319]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
—
—
—
—
—
—
0
29
547
5422
—
—
—
—
—
—
Open wound of knee
S81.0 [45545633]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
0
8
547
5443
—
—
—
—
—
0
11
455
4466
Benign neoplasm: Skin of lower limb, including hip
D23.7 [45581295]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
6
455
4471
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
0
11
547
5440
—
—
—
—
—
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.6e-02
1.1e-01
3.8e-01
—
2.4e-01
2.2e-01
1.7e-01
cases:37.29%
controls:36.69%
cases:28.88%
controls:26.66%
cases:7.68%
controls:5.39%
—
—
cases:5.67%
controls:4.50%
cases:30.70%
controls:26.25%
cases:50.77%
controls:46.42%
204
2000
343
3451
158
1453
389
3998
42
294
505
5157
—
31
245
516
5194
163
1380
368
3877
231
2078
224
2399
Extensive initial psychiatric evaluation
IBA04 [2001304046]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
17
547
5434
—
—
—
—
—
—
Major dressing of wound of skin of upper limb
QCB10 [2001309904]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Fear sexually transm disease male
Y25 [2002001393]
-1.0e+50
—
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:0.00%
controls:0.29%
0
14
547
5437
—
—
—
—
0
6
531
5251
0
13
455
4464
Extensive written report from radiologist
XX1XW [2001311008]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Scheduled procedure
ZXD10 [2001311387]
-1.9e-01
—
—
—
-1.0e+50
2.1e-01
-2.6e-01
cases:4.02%
controls:4.81%
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.94%
controls:0.76%
cases:1.98%
controls:2.55%
22
262
525
5189
—
—
—
0
5
547
5434
5
40
526
5217
9
114
446
4363
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
TEW99 [2001302349]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
0
6
547
5445
—
—
—
0
5
531
5252
—
Left ventricular failure
I50.1 [45543181]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
0
11
455
4466
Caught, crushed, jammed or pinched in or between objects
W23 [45756261]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
6
455
4471
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
0
13
531
5244
—
Other operation on bone of ankle or foot
NHK99 [2001308345]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
—
-1.0e+50
—
—
—
—
8.6e-01
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.47%
—
0
8
547
5443
—
—
—
—
5
21
450
4456
Adaptation disorder with short-term depression
F43.20 [2000502001]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Dentistry
C5 [903277]
4.8e-01
—
-1.0e+50
—
—
4.3e-01
6.2e-01
cases:2.93%
controls:1.83%
—
—
cases:0.00%
controls:0.13%
—
—
—
—
cases:1.51%
controls:0.99%
cases:3.52%
controls:1.92%
16
100
531
5351
—
0
7
547
5444
—
—
8
52
523
5205
16
86
439
4391
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
—
—
—
—
—
-1.0e+50
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
cases:1.10%
controls:0.34%
—
—
—
—
—
0
7
531
5250
5
15
450
4462
dexamethasone; local oral
A01AC02 [21600035]
2.8e-01
1.2e+00
—
—
—
—
8.0e-02
cases:1.65%
controls:1.25%
cases:1.10%
controls:0.35%
—
—
—
—
—
—
—
—
cases:2.20%
controls:2.03%
9
68
538
5383
6
19
541
5432
—
—
—
—
10
91
445
4386
Maternal care for (suspected) chromosomal abnormality in fetus
O35.1 [45606585]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
0
9
455
4468
Acute and subacute iridocyclitis
H20.0 [45542994]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
0
20
455
4457
Bacteria [Presence] in Urine
87829-8 [36304419]
-1.0e-01
—
—
—
—
6.9e-03
-2.5e-01
cases:4.39%
controls:4.82%
—
—
—
—
—
—
—
—
cases:2.26%
controls:2.24%
cases:4.62%
controls:5.83%
24
263
523
5188
—
—
—
—
12
118
519
5139
21
261
434
4216
Coxarthrosis, unspecified
M16.9 [45591742]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
0
21
547
5430
—
—
—
—
0
6
531
5251
—
Visual field testing with Humphrey automated perimetry
CS434 [2001301476]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
5
455
4472
Acute stress reaction
F43.0 [45591139]
—
—
—
—
—
—
2.5e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:1.21%
—
—
—
—
—
—
7
54
448
4423
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
-5.0e-01
1.9e-01
—
—
—
4.4e-03
-3.2e-01
cases:2.01%
controls:3.27%
cases:1.28%
controls:1.06%
—
—
—
—
—
—
cases:1.32%
controls:1.31%
cases:2.64%
controls:3.60%
11
178
536
5273
7
58
540
5393
—
—
—
7
69
524
5188
12
161
443
4316
Other specified dermatitis
L30.8 [45581941]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
—
0
6
531
5251
—
Simple extraction of IUD
TLC02 [2001306648]
1.1e+00
—
—
—
—
—
—
cases:0.91%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
5
17
542
5434
—
—
—
—
—
—
morphine; oral, parenteral, rectal
N02AA01 [21604256]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
0
7
455
4470
Bilateral
ZXA10 [2001311348]
8.1e-02
—
—
—
—
—
7.2e-02
cases:1.83%
controls:1.69%
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:1.23%
10
92
537
5359
—
—
—
—
—
6
55
449
4422
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 [3027544]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
0
7
547
5444
—
—
—
—
0
5
455
4472
Acute upper respiratory infection, unspecified
J06.9 [45562437]
1.0e-01
1.5e-01
1.7e-01
—
—
5.5e-02
1.0e-01
cases:12.43%
controls:11.36%
cases:6.03%
controls:5.23%
cases:0.91%
controls:0.77%
—
—
—
—
cases:5.65%
controls:5.36%
cases:16.70%
controls:15.32%
68
619
479
4832
33
285
514
5166
5
42
542
5409
—
—
30
282
501
4975
76
686
379
3791
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.36%
—
—
—
—
—
—
5
16
450
4461
warfarin; oral, parenteral
B01AA03 [21600965]
1.0e-01
2.7e-01
—
—
—
1.1e-01
3.0e-01
cases:1.83%
controls:1.65%
cases:1.46%
controls:1.12%
—
—
—
—
—
—
cases:1.32%
controls:1.18%
cases:1.98%
controls:1.47%
10
90
537
5361
8
61
539
5390
—
—
—
7
62
524
5195
9
66
446
4411
Reconstruction of areola and mamilla using graft or flap
HAE20 [2001303957]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
547
5446
—
—
—
—
—
—
plastic IUD with progestogen; implant
G02BA03 [21602449]
2.6e-01
—
—
—
—
3.7e-01
-8.1e-02
cases:4.02%
controls:3.14%
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.91%
cases:3.08%
controls:3.33%
22
171
525
5280
—
—
—
—
7
48
524
5209
14
149
441
4328
JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
80187-8 [21494670]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.22%
—
—
—
—
—
—
0
10
455
4467
Heartburn
R12 [45539318]
3.1e-01
—
—
—
—
—
3.0e-01
cases:1.10%
controls:0.81%
—
—
—
—
—
—
—
—
—
—
cases:1.54%
controls:1.14%
6
44
541
5407
—
—
—
—
—
7
51
448
4426
empagliflozin; oral
A10BK03 [1123740]
—
4.7e-01
1.0e+00
—
—
1.3e-01
7.8e-02
—
—
cases:1.28%
controls:0.81%
cases:0.91%
controls:0.33%
—
—
—
—
cases:1.13%
controls:0.99%
cases:1.98%
controls:1.83%
—
7
44
540
5407
5
18
542
5433
—
—
6
52
525
5205
9
82
446
4395
Migraine
N89 [2002000789]
8.9e-01
—
—
—
—
—
3.2e-01
cases:1.65%
controls:0.68%
—
—
—
—
—
—
—
—
—
—
cases:1.32%
controls:0.96%
9
37
538
5414
—
—
—
—
—
6
43
449
4434

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
21
46
4.70
9.13
2.9
1.2
—
—
nmol/l
—
0
0
22
56
4.05
7.95
3.6
1.3
0.46
0.50
nmol/l
0.32
22
51
318
2572
1.55
5.95
4.8
4.0
6.51
6.35
mmol/l
0.63
280
2358
187
1359
1.57
5.58
2.8
2.3
54.45
59.39
u/l
0.67
182
1276
208
1549
1.55
5.57
5.9
6.1
—
—
—
0
0
116
754
1.68
5.45
4.4
2.9
247.28
286.01
ng/l
0.10
82
465
104
657
1.72
5.42
3.0
2.0
15.06
14.24
umol/l
0.53
94
614
217
1646
1.52
5.27
10.3
7.6
1.11
1.12
inr
0.23
181
1339
165
1180
1.57
5.23
1.9
1.9
165.10
231.83
u/l
0.51
158
1128
96
603
1.71
5.10
3.0
2.0
2.54
2.42
g/l
1.19
88
557
280
2256
1.48
4.99
6.3
5.3
11.35
10.62
umol/l
0.37
272
2153
386
3326
1.52
4.88
4.4
4.0
—
2.87
—
0
7
17
54
3.22
4.52
1.4
1.9
23.05
30.78
ng/l
0.50
17
54
10
15
6.76
4.48
1.4
3.8
0.90
1.80
ug/l
—
10
15
535
5055
2.36
4.31
14.7
10.0
—
—
—
0
0
365
3159
1.45
4.12
4.3
4.0
4613.14
1803.95
e6/l
—
7
38
84
542
1.65
4.02
3.0
2.1
24.77
23.73
%
0.29
75
514
7
7
10.11
4.02
2.6
1.1
0.58
0.61
mmol/l
—
7
7
163
1223
1.47
3.97
2.5
2.3
2.51
2.65
mg/l
0.46
142
1056
154
1151
1.47
3.81
4.0
3.2
45.75
46.30
mg/l
0.01
89
732
270
2239
1.40
3.73
3.0
2.5
—
—
estimate
—
0
0
58
349
1.74
3.59
3.0
2.8
7.38
7.34
ph
1.43
41
244
154
1176
1.43
3.35
4.6
3.8
8.93
8.09
mg/mmol
0.09
88
719
10
292
0.33
3.30
1.2
1.6
—
—
—
0
0
61
382
1.67
3.28
2.3
2.9
1.70
1.82
%
0.56
55
348
550
5342
2.84
3.26
21.8
18.3
40.26
40.46
%
0.47
544
5303
550
5342
2.84
3.26
21.2
17.9
30.05
30.09
pg
0.21
544
5306
550
5342
2.84
3.26
21.3
18.0
4.52
4.53
e12/l
0.09
540
5256
550
5340
2.86
3.26
21.3
18.0
258.11
260.15
e9/l
0.35
539
5265
550
5340
2.86
3.26
21.2
17.9
89.80
90.17
fl
1.16
544
5305
312
2691
1.36
3.20
4.0
3.1
76.79
75.07
ug/l
0.10
300
2551
66
425
1.63
3.19
2.3
2.2
17403.49
6960.59
u/l
0.93
29
188
10
286
0.34
3.17
1.2
1.5
—
—
—
0
0
550
5345
2.80
3.13
21.5
18.1
135.20
135.45
g/l
0.18
544
5309
550
5344
2.81
3.12
21.3
18.0
6.82
6.69
e9/l
0.46
539
5254
9
20
4.56
3.12
5.2
4.3
63.22
154.40
nmol/l
—
9
20
27
132
2.10
3.12
1.6
1.4
260.54
296.88
ug/g
0.34
13
70
11
30
3.72
3.10
1.3
1.0
—
—
—
0
0
501
4707
1.62
3.07
14.9
11.9
139.64
139.63
mmol/l
0.04
486
4602
257
2161
1.35
3.06
2.9
2.5
74.50
74.70
nmol/l
0.04
247
1990
511
4825
1.69
3.06
13.3
11.4
16.64
21.04
mg/l
3.54
415
3817
478
4446
1.52
3.04
4.6
4.1
5.71
5.68
mmol/l
0.24
445
4154
236
1962
1.35
3.02
2.0
1.8
1.25
1.35
mmol/l
1.24
199
1733
501
4711
1.61
3.00
15.1
12.0
3.93
3.92
mmol/l
0.60
485
4589
182
1458
1.37
2.94
2.7
2.7
0.13
0.02
estimate
0.62
40
398
89
1220
0.68
2.86
3.3
2.6
0.34
0.35
e6/l
0.02
59
830
383
3445
1.35
2.80
8.3
6.7
73.28
76.39
u/l
1.08
370
3261
5
6
8.39
2.75
3.0
3.7
4.10
4.35
ug/l
—
5
6
245
2071
1.33
2.73
8.4
5.4
1.22
1.22
mmol/l
0.46
211
1783
133
1027
1.39
2.66
2.8
2.3
321.10
318.06
umol/l
0.13
121
924
45
277
1.68
2.61
2.3
2.7
65.16
73.08
e9/l
1.36
38
188
221
1856
1.32
2.53
6.9
4.9
1.22
1.22
mmol/l
0.81
207
1703
384
3485
1.33
2.45
3.7
3.0
33.60
38.54
u/l
1.14
366
3340
73
514
1.48
2.41
1.2
1.2
—
—
—
0
0
133
1050
1.35
2.30
1.3
1.3
16.42
31.93
iu/ml
2.24
44
275
171
1401
1.32
2.30
3.8
2.9
7.82
8.08
mmol/l
0.31
152
1218
183
2169
0.77
2.25
9.7
9.3
0.00
0.00
e9/l
1.40
148
1744
6
164
0.36
2.18
4.0
1.7
—
—
—
0
0
47
692
0.65
2.14
2.6
2.6
1.55
3.16
e6/l
1.95
24
311
525
5053
1.64
2.11
11.3
9.7
26.21
25.10
u/l
0.83
511
4932
484
4584
1.42
2.10
6.1
5.4
1.73
1.79
mu/l
0.62
460
4345
19
96
2.01
2.07
1.2
2.0
0.82
0.89
nmol/l
0.21
14
81
124
985
1.33
2.05
1.3
1.3
1.55
9.35
u/ml
4.85
40
380
53
363
1.51
2.02
9.0
7.7
7.41
7.42
ph
0.41
38
192
490
4663
1.41
1.95
4.8
4.2
4.71
4.75
mmol/l
0.47
465
4428
52
358
1.50
1.94
8.8
7.8
1.62
0.78
mmol/l
1.15
38
286
144
1733
0.77
1.93
3.5
3.4
74.85
62.22
e6/l
0.14
93
1096
70
514
1.41
1.88
1.6
1.4
—
—
—
0
0
523
5045
1.57
1.88
16.7
13.7
69.90
69.41
umol/l
0.25
515
4990
6
17
3.56
1.84
1.2
1.5
69.50
76.35
nmol/24h
—
6
17
5
12
4.19
1.82
1.4
2.5
15.00
9.33
%
—
5
12
208
1793
1.25
1.81
6.3
4.1
36.86
36.94
g/l
0.08
197
1696
487
4645
1.38
1.76
4.8
4.1
1.51
1.50
mmol/l
0.26
462
4393
53
376
1.45
1.73
1.3
1.2
—
—
—
0
0
60
807
0.71
1.71
3.0
2.4
2.41
2.43
mmol/l
0.64
54
717
141
1168
1.28
1.70
1.7
1.6
22.03
20.57
nmol/l
0.49
122
1018
491
4701
1.37
1.63
5.4
4.7
2.76
2.82
mmol/l
1.01
467
4452
5
14
3.59
1.62
1.4
2.2
27.00
27.64
%
—
5
14
116
1406
0.78
1.61
2.9
2.8
17.37
42.07
e6/l
1.89
81
1019
6
21
2.88
1.51
1.7
2.3
266.83
195.00
e6/l
—
6
21
158
1345
1.24
1.50
2.7
2.6
—
—
—
0
0
8
169
0.47
1.49
1.1
1.2
—
—
—
0
0
458
4364
1.27
1.41
4.0
3.6
1.21
1.22
mmol/l
0.10
432
4099
29
190
1.56
1.40
2.8
2.0
—
—
—
0
0
258
2326
1.20
1.37
5.5
5.9
54.92
56.28
%
1.35
248
2221
6
23
2.63
1.37
1.2
1.2
215.00
203.02
pmol/l
—
6
23
12
61
1.99
1.33
1.4
1.2
—
—
—
0
0
252
2272
1.20
1.33
6.1
6.1
0.78
0.68
%
0.80
240
2129
260
2354
1.20
1.30
5.9
6.0
31.17
29.50
%
1.79
252
2245
8
34
2.37
1.29
1.0
1.1
12.13
7.91
mm/h
—
8
34
252
2277
1.19
1.29
5.9
6.0
2.90
2.76
%
0.51
240
2142
21
327
0.63
1.29
18.0
7.6
—
—
—
0
0
73
577
1.30
1.28
2.8
3.3
3.56
5.42
e9/l
1.97
62
521
207
1842
1.20
1.24
2.1
1.9
100.26
97.59
pmol/l
0.33
115
982
47
349
1.38
1.24
3.6
3.7
4.67
4.63
pmol/l
0.11
42
313
49
367
1.37
1.23
2.6
2.4
10.80
10.59
g/l
0.13
44
340
421
3997
1.22
1.20
5.2
4.5
14.63
14.45
pmol/l
0.84
390
3736
327
3036
1.19
1.19
3.2
3.1
—
0.00
—
0
5
252
2289
1.18
1.19
6.1
6.1
8.44
8.42
%
0.03
240
2154
14
79
1.79
1.18
5.2
3.8
3.72
4.09
e9/l
0.29
14
79
138
1188
1.21
1.17
3.0
3.2
1.02
1.02
kg/l
0.31
102
752
445
4252
1.23
1.17
6.3
4.9
38.04
37.45
mmol/mol
0.75
426
4035
76
612
1.28
1.17
1.4
1.2
—
—
—
0
0
7
30
2.35
1.12
1.0
1.1
1460.86
1335.30
miu/ml
—
7
30
71
572
1.28
1.09
1.9
1.6
1196.55
1187.78
nmol/l
0.03
51
435
12
204
0.58
1.07
2.6
2.2
0.79
0.60
%
1.34
12
204
15
240
0.61
1.06
1.5
1.5
0.33
0.30
mg/l
—
8
98
14
82
1.73
1.06
1.3
1.2
—
—
—
0
0
53
413
1.31
1.05
1.4
1.3
17.34
20.37
iu/l
0.46
47
352
7
34
2.07
1.03
1.0
1.2
—
—
—
0
0
5
109
0.45
1.01
1.0
1.1
—
—
—
0
0
42
320
1.34
0.98
5.2
4.2
1.83
23.75
ug/l
0.98
30
262
7
37
1.90
0.94
2.9
2.8
—
—
—
0
0
9
52
1.74
0.92
1.0
1.2
—
—
—
0
0
166
1484
1.17
0.92
1.4
1.4
2.20
2.12
u/ml
0.02
40
402
6
29
2.08
0.89
3.2
2.5
—
—
—
0
0
8
42
1.92
0.89
2.3
2.0
38.01
42.35
%
—
8
42
95
813
1.20
0.87
2.2
2.8
90.57
101.05
ug/g
0.22
82
651
24
170
1.43
0.86
2.0
1.7
—
15.51
—
0
7
11
64
1.73
0.86
1.7
1.7
—
—
—
0
0
141
1251
1.17
0.86
5.1
3.3
7.40
7.40
ph
0.02
111
866
13
80
1.64
0.85
4.2
1.9
8.88
5.67
pmol/l
0.34
13
80
94
806
1.20
0.85
1.5
1.6
412.84
30072365.40
pmol/l
1.08
81
695
48
383
1.28
0.83
1.3
1.2
147.17
266.38
u/ml
0.66
43
362
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
37
473
0.77
0.81
10.1
6.5
104.24
104.56
mmol/l
0.22
37
473
8
47
1.71
0.81
1.6
1.8
—
—
—
0
0
186
1693
1.15
0.80
3.7
3.1
27.39
29.81
u/l
1.03
176
1620
29
217
1.35
0.78
1.4
1.3
11.15
9.02
u/l
0.42
23
166
423
4377
0.86
0.77
17.4
15.1
334.32
332.71
g/l
3.19
423
4360
37
288
1.30
0.77
2.5
2.0
11.33
12.52
nmol/l
0.30
32
265
0
28
0.00
0.76
0.0
2.4
—
12.47
—
0
20
282
2647
1.13
0.75
3.2
3.4
0.00
0.01
estimate
0.50
48
477
5
24
2.09
0.74
1.6
1.2
58.00
102.33
nmol/l
—
5
16
45
362
1.26
0.74
2.9
2.5
0.23
0.22
g/l
0.40
45
338
7
38
1.85
0.73
1.1
1.1
194.29
199.06
mg/l
—
7
33
19
135
1.42
0.70
2.2
3.7
381.17
234.31
mg/l
—
6
65
212
1966
1.13
0.68
3.1
3.1
0.20
0.03
estimate
0.82
41
416
7
43
1.64
0.67
1.3
1.1
134.71
121.49
pmol/l
—
7
43
7
44
1.60
0.65
1.1
1.1
—
—
—
0
0
28
216
1.31
0.64
1.6
1.7
—
—
—
0
0
278
2625
1.12
0.64
3.2
3.3
0.00
3.27
estimate
0.50
49
497
8
49
1.64
0.62
4.4
1.3
—
—
—
0
0
8
49
1.64
0.62
4.4
1.3
—
—
—
0
0
8
49
1.64
0.62
4.4
1.3
—
—
—
0
0
8
49
1.64
0.62
4.4
1.3
—
—
—
0
0
5
30
1.67
0.61
2.0
1.1
—
—
—
0
0
143
1305
1.13
0.59
1.9
1.7
—
—
—
0
0
16
114
1.42
0.59
5.1
3.1
55.44
57.39
%
0.20
16
114
122
1105
1.13
0.57
2.3
1.8
0.84
1.01
mg/l
0.66
94
831
82
925
0.87
0.56
2.8
2.2
5.40
7.95
e6/l
1.36
70
816
62
535
1.18
0.55
3.3
2.2
4.75
6.68
umol/l
1.52
51
464
69
788
0.86
0.55
2.8
2.4
533.07
552.32
mosm/kgh2o
0.24
58
677
274
2602
1.10
0.55
5.5
6.4
0.19
0.18
e9/l
0.48
242
2294
157
1448
1.12
0.55
2.6
2.8
32.20
77.77
ng/l
0.42
69
790
6
38
1.59
0.54
1.0
1.1
—
—
—
0
0
166
1537
1.11
0.54
2.4
2.0
—
—
—
0
0
40
332
1.22
0.54
4.0
4.1
1.00
0.72
%
0.20
15
85
6
100
0.60
0.52
1.0
1.0
—
—
—
0
0
30
367
0.81
0.50
1.4
1.6
—
—
—
0
0
137
1261
1.11
0.50
1.4
1.4
2.06
2.18
g/l
0.51
90
809
25
311
0.79
0.49
1.6
1.8
—
—
—
0
0
16
119
1.35
0.48
7.6
3.1
1.33
1.25
mg/l
0.19
16
108
13
94
1.39
0.46
2.0
2.2
127.62
132.95
g/l
—
8
73
33
394
0.83
0.45
1.7
1.4
—
—
—
0
0
45
386
1.18
0.45
3.8
3.1
—
—
—
0
0
7
50
1.40
0.45
6.6
4.1
15.61
18.53
u/ml
—
7
50
10
69
1.46
0.44
1.0
1.1
—
—
—
0
0
21
166
1.28
0.44
2.3
3.0
—
—
—
0
0
134
1443
0.91
0.43
4.3
5.8
—
—
—
0
0
59
520
1.15
0.43
1.7
1.5
—
—
—
0
0
33
391
0.83
0.42
1.7
1.4
—
—
—
0
0
12
87
1.39
0.42
1.1
1.2
—
—
—
0
0
8
57
1.41
0.42
1.1
1.2
413.50
408.89
pmol/l
—
8
51
11
150
0.73
0.42
1.1
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
2.4
—
17.19
—
0
15
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
16
123
1.31
0.41
1.3
1.2
—
—
—
0
0
16
123
1.31
0.41
1.4
2.3
9.21
10.96
mg/l
0.55
16
116
0
18
0.00
0.40
0.0
1.8
—
146.67
—
0
18
8
61
1.32
0.39
1.5
1.4
—
—
—
0
0
272
2613
1.08
0.38
3.2
3.3
0.00
0.00
estimate
0.50
47
497
86
941
0.90
0.38
1.6
1.6
—
—
—
0
0
112
1208
0.91
0.38
4.2
4.1
—
—
—
0
0
5
37
1.35
0.37
2.2
2.4
—
—
—
0
0
32
374
0.85
0.37
4.4
2.8
7.37
7.38
ph
0.53
21
205
175
1658
1.08
0.35
1.6
1.7
—
—
—
0
0
9
125
0.72
0.35
1.1
1.5
72.22
220.32
e6/l
—
9
98
36
311
1.17
0.35
2.3
2.3
21.23
42.71
u/ml
0.94
30
297
22
181
1.22
0.35
1.4
1.2
—
—
—
0
0
34
393
0.86
0.35
1.7
1.5
—
—
—
0
0
35
302
1.17
0.35
5.1
3.1
1.24
1.23
mmol/l
0.38
30
254
67
607
1.12
0.34
5.4
4.8
1.64
1.80
ug/l
0.24
62
549
27
230
1.18
0.31
3.7
2.8
7.41
7.42
ph
0.09
22
196
34
389
0.87
0.31
1.6
1.5
—
—
—
0
0
28
240
1.18
0.30
1.3
1.9
11.70
5.80
iu/ml
—
5
58
33
287
1.16
0.30
1.4
1.2
—
—
—
0
0
46
514
0.89
0.30
1.5
1.3
—
—
—
0
0
7
55
1.28
0.30
1.4
1.2
—
—
—
0
0
198
1897
1.07
0.29
2.3
1.9
—
—
—
0
0
82
761
1.09
0.28
1.5
1.4
556.67
522.03
titre
0.06
24
158
17
140
1.22
0.27
2.2
2.1
3.01
5.24
umol/l
2.10
12
106
32
363
0.87
0.27
1.6
1.4
—
—
—
0
0
8
66
1.22
0.27
1.5
1.3
—
—
—
0
0
14
171
0.81
0.26
1.1
1.1
—
—
—
0
0
9
72
1.25
0.25
2.4
2.2
—
—
—
0
0
258
2502
1.06
0.25
5.4
6.1
0.54
0.55
e9/l
0.23
229
2162
68
630
1.09
0.24
1.6
1.6
1005.72
973.01
mu/l
0.15
62
525
24
208
1.16
0.24
1.5
1.6
9.55
7.43
u/ml
—
8
50
131
1375
0.94
0.24
3.0
3.4
0.04
0.00
estimate
0.43
45
467
220
2129
1.05
0.23
3.0
3.0
6.11
6.20
ph
0.71
137
1176
5
38
1.32
0.23
1.4
1.1
—
—
—
0
0
34
304
1.13
0.23
1.5
1.4
—
—
—
0
0
258
2509
1.05
0.23
5.4
6.1
0.04
0.04
e9/l
0.16
230
2166
37
334
1.12
0.22
5.1
4.2
0.08
0.16
%
0.33
12
77
5
41
1.22
0.22
1.8
1.6
—
—
—
0
0
68
634
1.08
0.22
4.7
2.6
0.80
0.82
mmol/l
1.46
63
602
10
124
0.80
0.22
1.0
1.3
3.71
3.62
mmol/l
—
10
115
46
421
1.10
0.21
1.5
1.9
0.00
0.03
estimate
—
7
95
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
8
101
0.79
0.21
1.3
1.1
—
—
—
0
0
153
1590
0.95
0.20
2.0
2.1
—
—
—
0
0
142
1478
0.95
0.20
3.7
2.7
2.36
2.35
mmol/l
0.22
129
1345
6
49
1.23
0.20
1.5
1.6
267.67
278.23
mosm/kgh2o
—
6
35
13
154
0.84
0.19
1.1
1.1
0.86
3.58
u/ml
—
7
84
263
2568
1.05
0.19
5.5
6.0
1.95
2.00
e9/l
0.31
236
2288
7
58
1.21
0.18
11.7
1.9
—
—
—
0
0
54
504
1.08
0.17
7.2
3.6
1.03
1.05
mmol/l
0.17
48
463
95
996
0.94
0.17
4.0
3.5
—
—
—
0
0
57
534
1.08
0.17
1.3
1.2
—
—
—
0
0
51
546
0.93
0.17
1.7
1.7
3.36
3.43
mmol/l
0.21
35
378
24
216
1.12
0.15
1.1
1.2
—
0.87
—
0
14
9
83
1.09
0.14
2.0
1.6
203.11
225.49
pmol/l
—
9
78
54
571
0.94
0.13
1.8
1.3
—
—
—
0
0
37
345
1.08
0.13
5.1
4.7
0.50
0.14
%
0.32
12
74
50
527
0.94
0.12
1.4
1.5
—
—
—
0
0
51
487
1.05
0.10
1.3
1.3
156.52
151.73
u/ml
0.03
19
195
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
37
353
1.05
0.07
5.2
4.2
0.92
0.90
%
0.01
12
96
26
245
1.06
0.07
1.4
1.1
0.83
0.89
g/l
0.74
26
245
7
83
0.84
0.07
2.6
4.0
—
—
—
0
0
11
99
1.11
0.06
2.0
2.2
—
—
—
0
0
202
2045
0.98
0.06
2.8
2.6
—
—
—
0
0
12
109
1.10
0.06
1.1
1.4
—
—
—
0
0
28
294
0.95
0.06
1.0
1.1
—
—
—
0
0
23
242
0.95
0.05
1.4
1.2
—
—
—
0
0
10
91
1.10
0.04
1.3
4.2
22.91
38.50
mg/l
—
10
78
10
91
1.10
0.04
1.3
4.2
22.50
29.86
mg/l
—
10
79
26
271
0.96
0.04
1.0
1.1
—
—
—
0
0
40
389
1.03
0.03
2.1
2.1
6.38
6.19
ph
0.40
16
259
11
102
1.08
0.03
1.9
1.2
—
—
—
0
0
275
2762
0.99
0.02
6.8
8.7
3.79
4.00
e9/l
1.12
243
2388
10
93
1.08
0.02
1.0
1.1
—
—
—
0
0
11
103
1.07
0.02
1.1
1.0
0.05
5.94
u/ml
—
5
43
17
177
0.96
0.01
1.1
1.6
0.25
0.23
g/l
0.37
17
167
38
387
0.98
0.01
2.8
2.7
0.75
0.72
ug/l
0.06
19
240
59
583
1.01
0.01
2.4
1.7
—
—
—
0
0
12
114
1.05
0.00
1.0
1.1
4.73
2.30
eliau/ml
—
6
57
19
184
1.03
0.00
1.1
1.5
1.16
1.19
g/l
0.22
19
174
16
155
1.03
0.00
1.6
1.3
—
—
—
0
0
11
106
1.04
0.00
1.7
1.2
1.83
6.19
u/ml
—
6
42
17
175
0.97
0.00
2.8
2.2
2.32
3.95
iu/l
—
7
78
22
224
0.98
0.00
1.1
2.2
—
—
—
0
0
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
14
137
1.02
0.00
1.1
1.1
—
—
—
0
0
23
227
1.01
0.00
1.2
1.2
—
—
—
0
0
24
243
0.99
0.00
1.2
1.1
1.60
1.55
g/l
0.42
24
243
109
1094
1.00
0.00
1.9
1.8
—
—
—
0
0
28
278
1.01
0.00
1.3
1.4
268.27
270.14
miu/ml
0.01
15
145
5
56
0.89
0.00
1.2
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.2
1.6
27.35
36.22
nmol/l
—
5
49
0
5
0.00
-0.00
0.0
4.0
—
5.08
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.9
—
27.11
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.04
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
79
790
1.00
-0.00
1.5
1.6
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.3
77.83
75.74
mmol/l
—
6
54
0
5
0.00
-0.00
0.0
1.2
—
64.00
—
0
5
0
6
0.00
-0.00
0.0
1.5
—
34.83
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FAMILY_HISTORY_OTH_SPECIFIC_DISORD – Family history of other specific disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).